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Abstract
In Vitro Directed Evolution of Fluorescence-Enhancing and
Structure-Switching RNA Aptamers
Michael Roy Gotrik
Genetically-encoded fluorescent proteins have become an essential tool, and
researchers today have access to a diverse array of protein-labeling strategies
for studying fundamental in vivo processes. However, there exist relatively few
methods for in vivo detection of an equally important biomolecule RNA. One
useful method to track RNA entails fusing the cellular RNA of interest to an RNA
aptamer that can bind to and turn on the fluorescence of a small-molecule dye.
Unfortunately, it is difficult to discover such fluorescence-enhancing RNA aptamers.
This is because the conventional method of aptamer discovery (SELEX) can enrich
for RNA that binds to a dye, but it does not preferentially identify sequences that
generate a fluorescent signal upon binding. Thus, there is a critical need for a
method capable of directly screening RNA aptamers for fluorescence enhancement.
To address this need, we have developed a strategy for rapidly and intently
screening large numbers of RNA aptamers based on their capacity to generate
a fluorescent signal upon binding a small-molecule dye. Our approach generates
libraries of Gene-linked RNA Aptamer Particles (GRAPs) that display functional
viii
RNA aptamers and are isolatable using fluorescence-activated cell sorting (FACS).
As proof of concept, we performed selections isolating fluorescence-enhancing
aptamers against malachite green (MG). We show that by directly selecting for
function rather than binding, we can isolate RNA aptamers that are brighter and
higher affinity than the best known MG aptamer. GRAP display also enables us to
measure the fluorescence signal of every aptamer across multiple emission windows,
permitting us to reconstruct the emission profile of every displayed aptamer. This
in turn, allows us to intentionally isolate aptamers that fluoresce at a variety of
wavelengths upon binding their target dye. Lastly, this technique can be used to
discover functional RNA that undergoes a structural re-organization upon ligand
binding. This has promising implications in the fields of biosensing, gene therapy,
and cellular computing. This flexibility should greatly expand the toolbox of
reagents available for studying RNA in vivo.
ix
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Chapter 1
Introduction
1.1 Fluorescence Biology
Since the discovery of the green fluorescent protein (GFP) in 1962 [1] and its first
recombinant expression 32 years later [2,3], GFP and its many derivatives have
helped revolutionize nearly all fields relating to biology. Through application with
a number of technologeis, fluorescent proteins (FPs) allow researchers to visualize
structures and processes in living systems that would otherwise be unobservable.
For example, FPs have played key roles in determining how proteins localize
in the cell [4,5], developing and studying complex intracellular networks [6,7], and
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performing cellular microscopy below the diffraction limit [8]; among numerous
other functions [9–11].
FPs are widely used in part because they can be expressed in vivo and function
without requiring external catalysts or cofactors [9]. This means the proteins can
be synthesized and assembled in a cell and fluorescent measurements can be
made while requiring little perturbation of the expressing system. Though FPs
have allowed fantastic advancements in understanding protein biology, there exist
few methods of studying the well-known precursors of proteins - nucleic acids
(DNA or RNA). This is because, except for the so-called ”Y base” in the tRNA
of yeast [12], there is no naturally fluorescent nucleic acids. In other words, no
natural nucleic acid sequence, without the addition of external organic dyes, will
itself assemble into a self-fluorescing system [13]. Thus, while our understanding
of protein biology is constantly improving, we remain mostly ”in the dark” when
it comes to understanding the complex roles that DNA and RNA can play in
the cell. To understand how best to address this issue, it is helpful to gain a
basic understanding of the physical processes at play that causes a molecule to
fluoresce.
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1.2 Properties of Fluorescent Molecules
Though the earliest written account of fluorescence is as early as 1565 [14], William
Herschel [15] described the fluorescence phenomenon well in 1845 when he wrote:
Equal weights of the sulphate (of quinine) and of crystallized tar-
taric acid, rubbed up together with addition of a very little water,
dissolve entirely and immediately. It is this solution, largely diluted,
which exhibits the optical phenomenon in question. Though perfectly
transparent and colorless when held between the eye and the light, or
a white object, it yet exhibits in certain aspects, and under certain
incidences of the light, an extremely vivid and beautiful celestial blue
colour, which, from the circumstances of its occurrence, would seem to
originate in those strata which the light first penetrates in entering the
liquid.
The event that Herschel described was that of quinine becoming excited by sunlight
and yielding a ”celestial blue” fluorescence emission. Though inexplicable at the
time, the mechanism of fluorescence has since become a well-established theory.
Simply put, fluorescence is the result of an electron in a molecule entering an
excited singlet state due to absorption of light, and then returning to its ground
(unexcited) state with the emission of a photon. This process is rapid (a typical
lifetime being around 10 nanoseconds) [16], yet can vary wildly depending on the
chemical properties of the excited compound. While many materials are known to
exhibit fluorescence (e.g. quantum dots, divalent manganese or europium salts,
FPs) the most common class of fluorescent molecules are organic. This is because
organic, aromatic compounds that contain large delocalized pi systems can strongly
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absorb incoming light. Thus, many electrons enter the excited singlet state which
is a necessary precursor for fluorescence. These aromatic compounds, often called
chromophores due to their propensity to absorb in the visible range, are then able
to release the absorbed energy through radiative (i.e. fluorescence) or non-radiative
(i.e. thermal) processes. To transform a light-absorbing chromophore into a light-
emitting fluorophore simply involves the reduction of non-radiative decay channels
in favor of radiative channels. This can be achieved through covalent or steric
restriction of rotational and vibrational modes.
Chromophores that fluoresce upon steric restriction of non-radiative decay chan-
nels form an interesting class of molecules termed ”molecular rotors [17].” Usually,
these chromophores are non-fluorescent when free in solution but are ”turned on”
when their intramolecular rotations become constrained by an outside actor. This
process, aptly termed ”restriction of intramolecular rotation [18]” (RIR), is widely
exploited in the study of materials that undergo aggregation-induced emission
(AIE) [19]. In this process, a chromophore will self-aggregate upon precipitation
from a solution at which point fluorescence becomes its primary decay mechanism.
RIR can also be induced through specific interaction with a given biomolecule.
These types of interactions are possible with so-called ”affinity reagents” which
bind tightly and specifically to their target molecule. For example, a collection of
”blue-fluorescent antibodies” were developed [20] that activate derivatives of stilbene
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Figure 1.1: Chemical structures for stilbene (A) and 3,5-difluoro-
4-hydroxybenzylidene imidazolinone (DFHBI, B). The rotation modes that must
be restrained in each molecule in order to activate fluorescence are indicated by
red arrows.
(Figure 1.1 A). Likewise, the well-known Spinach RNA aptamer interacts with and
activates 3,5-difluoro- 4-hydroxybenzylidene imidazolinone (DFHBI, Figure 1.1 B).
This demonstrates how non-fluorescent biomolecules can be made to fluoresce by
interacting with and ”turning on” an external chromophore.
1.3 Aptamers as Affinity Reagents
Beyond their role in enhancing the fluorescence of chromophores, affinity reagents
that bind tightly and specifically to a target molecule are an indispensable tool in
biological and medical research, diagnostic tests, pharmaceuticals, and targeted
therapies. Indeed, virtually every field of research in biomedicine relies to some
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degree on being able to recognize and act upon a molecule of interest. Antibodies
are most commonly used in this role, owing to their immense chemical diversity
and functionality, excellent recognition abilities, and the enormous infrastructure
in place for discovering, characterizing, and disseminating these reagents. Indeed,
as of 2011, there was estimated to be over 500,000 unique antibodies towards over
15,000 targets available to researchers [21,22] worldwide.
Because antibodies are isolated through exploitation of a live animal’s immune
system, their discovery is inherently costly and it can be difficult to identify
antibodies against toxic, unstable, self-similar, or non-immunogenic targets [23].
Oftentimes, the resulting antibodies can themselves exhibit immunogenicity and
thus be unsuitable for invivo and medical treatment applications [24,25] In addition
to these problems, numerous large-scale antibody validation studies have shown
that there exists widespread issues with the reported specificity and reproducibility
of commercially-available antibodies [26–28]. For example, an antibody validation
project reported in 2007 that of nearly 18,000 antibodies characterized, only
about 35% were shown to work for their intended purposes [21]. For these reasons
and others, there is growing interest in affinity reagents that can perform the
same functions as antibodies while being inexpensive, reproducible, and easily
disseminated [29–34].
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Aptamers - whose names is derived from the Latin aptus meaning ’to fit’ - are
short oligonucleotides that bind to or ”fit” their target molecule. Aptamers can
perform many of the same functions as antibodies with a number of important
differences. Whereas antibodies gain their extensive chemical functionality through
utilization of the 20 natural amino acids; nucleic acid aptamers gain their properties
from their sugar backbone (ribose in RNA, deoxyribose in DNA) and combinations
of the 5 nucleobases - adenine (A), guanine (G), cytosine (C), thymine (T, DNA-
specific), and uracil (U, RNA-specific). By adopting complex 3-dimensional
structures and displaying their nucleobases in precise spatial orientations, aptamers
bind their targets through non-covalent interactions such as hydrogen bonding,
charge-charge interactions, and Van der Waals forces [35]. While aptamers are
generally considered to bind less-tightly (having low affinity), less-specifically, and
to fewer potential targets than antibodies; many aptamers have been discovered
with picomolar affinity [36,37]; unparalleled specificity [38,39]; and against targets such
as proteins [40], small molecules [41], whole cells [42,43], and more [44,45]. One common
example of these capabilities is an aptamer against the small molecule theophylline
which has a >10,000-fold reduced affinity to caffeine on the basis of a single methyl
group difference [38].
Discovered concurrently in the labs of Larry Gold [46] and Jack Szostak [47] in
1990, aptamers have since been shown to hold incredible promise to supplement or
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otherwise replace antibodies in many applications [29,48]. This is because antibodies
are proteins discovered through the exploitation of a live animal’s immune system
and thus naturally possess a number of disadvantages when compared to aptamers.
For example, while antibodies must be produced by living systems and distributed
as a physical specimen, nucleic acid aptamers can be reproducibly synthesized using
well-established chemistries and can be shared digitally as sequence information.
This greatly reduces the per-mole cost of aptamers compared to antibodies and
lends to their unparalleled reproducibility [25,49].
The purely synthetic nature of aptamers makes them amenable to chemical and
structural modifications in order to improve their affinity, specificity, and chemical
or thermal stability [29,50]. They can be easily modified to include fluorophores
for use as biosensors [51–53] and unnatural backbones, sugars, and nucleobases to
improve function and nuclease resistance in vivo [54–56]. In addition, aptamers are
generally thermo-stable and, if they become improperly folded at any time during
their application, they can often be correctly refolded by simple temperature
cycling - a capability rarely allowed by proteins. This means aptamers are more
tolerant to prolonged storage and environmental variability to which antibodies
are highly susceptible [27,57]. Lastly, aptamers are mostly discovered through a
process of in vitro directed evolution meaning they can address a host of targets
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that are incompatible with in vivo antibody discovery - including highly toxic,
non-immunogenic, and biologically-labile targets [29].
1.4 Systematic Evolution of Ligands by
Exponential Enrichment (SELEX)
To understand the advantages that aptamers hold and the challenges they have
yet to overcome, it is necessary to be cognizant of the method by which they are
discovered. The process, termed Systematic Evolution of Ligands by EXponential
enrichment [47] (SELEX) begins with a large diverse ”library” of random sequences.
Though it is possible to derive libraries from genomic DNA [58] or transcriptomic
sources [59] and using modified nucleotides [60–63], the most common method is to
produce the library using phosphoramidite chemistry. During the synthesis process,
the library is designed to incorporate 20≈80 ”random” bases; or bases that have
an equal probability to be any of the four nucleobases.(Figure 1.2 A). This random
region is surrounded on either side by constant primer binding sites which are
necessary to amplify and manipulate the library using polymerase chain reaction
(PCR), transcription, and other enzymatic methods of synthesis, replication, or
digestion. Because each random base is one of four possibilities (A,T/U,C, or G),
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the total library diversity scales as 4n where n is the total number of random bases.
Thus, the theoretical diversity of a typical library is generally 1012 ≈ 1048.
Because of physical restraints on the amount of DNA that can be feasibly used,
each round of SELEX begins with a pool containing around 1014 sequences (<1
nanomole). This pool undergoes a cyclical process (Figure 1.2 B) wherein it is first
exposed to the molecule of interest, target-bound sequences are separated from
unbound sequences (which are discarded), and bound sequences are recovered for
use in further rounds of SELEX. If DNA is used in this process, the recovered
sequences are PCR amplified and the antisense strand is enzymatically digested to
regenerate the pool. If performed using RNA, collected sequences are first reverse
transcribed into DNA, PCR amplified, and then transcribed into RNA to start the
next round. Though dozens of variants of SELEX have been described [64], they
often rely on these basic principles. Typically, over the course of 6-20 rounds, the
starting pool goes from containing ≈ 1014 unique sequences, to being primarily
made up of a small number of unique sequences that recognize and bind to the
target molecule. The rapidity and magnitude of pool convergence (reduction of
pool diversity) oftentimes determines whether a selection is deemed a success or
failure. If no convergence occurs, suitable candidates cannot be identified.
It is important during SELEX to monitor when and how quickly convergence
occurs, as it is desirable to use the fewest number of rounds in order to minimize
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Figure 1.2: Systematic Evolution of Ligands by EXponential Enrichment
(SELEX) Process. A) Typical library design for use in directed evolution. RNA
polymerase promoter region (green) is only necessary when performing SELEX
using an RNA library. B) Selection scheme for SELEX. Step 1: A random pool
of single-stranded nucleic acids is incubated with an immobilized target. Step 2:
Unbound sequences are removed and discarded. Step 3: Bound sequences are
reverse-transcribed (RNA only) and amplified using PCR. Step 4:
Double-stranded DNA is regenerated into a single-stranded aptamer pool through
exonuclease digestion (DNA) or reverse-transcription (RNA). Steps 1-4 are
typically repeated 6-20+ times until pool converges to a handful of functional
sequences. Step 5: Pool undergoes sequencing and candidate aptamers are
characterized.
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time, resources, and biases (see Section 1.6) inherent to the process. Convergence
of a pool is sometimes monitored by measuring the amount of recovered nucleic
acids (e.g. using qPCR [65] or a radio-labeled library [66]) or the bulk binding
affinity of the library (e.g. using fluorescence-activated cell sorting (FACS) [67],
filter binding [68], or capillary electrophoresis [69]). When the pool is measured or
shows indications of convergence, it undergoes sequencing in order to identify
potential aptamer candidates. Upon sequence analysis, suitable candidates are
synthesized and characterized in order to identify the best-performing aptamers.
Though some ambiguity exists in the exact meaning of the term ”aptamer”, in this
dissertation it refers to nucleic acid sequences that exhibit function (e.g. binding,
catalysis, switching, etc.) and are designed or discovered using directed evolution
(e.g. SELEX).
1.5 Functional Nucleic Acids and Their
Application
While DNA and RNA are best known as messengers of genetic information,
researchers are constantly identifying new and interesting functions of these nucleic
acids in nature. While it was once believed that 99% of the genome (that is, the non-
protein-coding regions) was simply ”junk” DNA, this idea has largely fallen wayside
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as researchers continue to find new and interesting biological and biochemical
roles of these non-coding nucleic acids in vivo. For example, the Encyclopedia of
DNA Elements (ENCODE) Project [70], announced in 2012, estimates that >75%
of the human genome is biochemically active and transcribed into non-coding RNA
serving a variety of purposes [71].
Functional RNA is, in fact, ubiquitous in cellular biology. In the ribosome,
for instance, protein plays a primarily structural role [72]; while ribosomal RNA
(rRNA) is responsible for reading messenger RNA (mRNA), aligning transfer RNA
(tRNA) to the correct mRNA codon, and catalyzing the transfer of amino acids
onto the peptide chain of a protein undergoing translation [73]. Encouraged by
the catalytic potential of nucleic acids, large numbers of ribozymes (RNA-based)
and deoxyribozymes (DNA-based, also called DNAzymes) have been evolved and
characterized over the last 20 years spanning a multitude of catalytic reactions
both chemical and biochemical [74–76]. Together, these discovered catalytic nucleic
acids are often called aptazymes - a portmanteau of aptamer and enzyme. Aside
from catalytic roles, non-coding RNAs are also found to play roles in subcellular
structural organization [77,78]; promote gene silencing [79,80], gene expression [81,82],
and stem cell differentiation [83]; determine macromolecular localization [84]; and
many other functions [81,85,86].
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1.5.1 Nucleic Acid Switches
While aptamers do not currently possess the depth nor range of applications
performed by the various functional nucleic acids in vivo, aptamers have been
discovered that can perform many interesting functions that other affinity reagents
are yet incapable of addressing. For example, many aptamers can fold reversibly
and specifically in the presence of their target and find use as molecular sensors [87].
This folding is often a result of intermolecular interactions whereby a separate,
complimentary nucleic acid interacts with the aptamer until introduction of an
external ligand that results in an energetically more-favorable folding state. A
measurable change in structure is then coupled to arbitrary downstream processes
and can yield a variety of applications such as real-time small molecule [88,89],
metal ion [90], and protein detection [91,92]. For example, a structure-switching
DNA aptamer has been utilized to measure [93] and then control [94] the levels of
an important cancer drug - doxorubicin - in live animals. This was done by
coupling a structure-switching aptamer to an electrode inside a microfluidic chip
and monitoring folding through an electronic signaling cascade which is directly
correlated to a real-time target concentration.
Riboswitches are a specific class of structure-switching RNA that are commonly
found in bacteria and viruses as one manner of regulating gene expression [95,96](see
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Figure 1.3: Mechanisms of gene regulation for natural and synthetic
riboswitches. In orange are mechanisms used by bacteria, while blue shows
eukaryotic (primarily yeast) mechanisms. a) In the ligand-bound form, a
terminator hairpin causes transcription termination. b) A structural change
prevents occupation of the ribosome-binding site (RBS) causing translation
inhibition upstream of the open reading frame (ORF). c) Destabilization of folded
RNA leads to rapid ribozyme degradation. d) Splice sites are reorganized through
a structural change, leading to an alternate form of the mature mRNA. e)
Translation start site is altered so as to be unrecognizable by the ribosome. f)
5′-7- methylguanosine cap is cleaved by ribozyme to prevent ribosome progression.
g) Removal of poly-A tail in eukaryotes by ribozyme leads to rapid mRNA
degradation. Reproduced with permissions [95].
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Figure 1.3). They work by affecting gene expression through conformational
change but only when in the presence of an external stimuli - typically a small
molecule [96–99]. Riboswitches are a particularly promising topic in the field of RNA
aptamers, as successful design and implementation can allow functional expression
of ’RNA machines’ or genetic logic gates [100] in situ. While naturally used for gene
expression, riboswitches have been engineered and expressed in vivo to, among
other functions, allow the real-time monitoring of cellular metabolites [101–103] and
the modulation [104] or de novo engineering [105,106] of signaling pathways.
1.5.2 Fluorescence-Enhancing Aptamers
An important class of aptamers has been recently developed that binds to and
activates the fluorescence of weakly- or non-fluorescent small molecule dyes. As
mentioned in Section 1.1, these dyes consist of an electron donor and acceptor
connected through a large, pi-conjugated network. When these chromophores are
unrestricted, the energy from absorbed photons is able to be released through
non-radiative processes such as vibration or rotation. However, upon restriction
of intramolecular rotation [18] by interaction with an aptamer, the absorbed en-
ergy can be made to release through radiative processes. The first fluorescence
enhancing aptamer [107] was against malachite green (MG) and was found to en-
hance the fluorescence of MG by 2400-fold above background [55]. Since then,
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fluorescence enhancing aptamers against thiazole orange [108] and derivatives of
4-(p-hydroxybenzylidene)imidazolidin-5-one (HBI) [109–111] - the active molecule
in green fluorescent protein (GFP) - have been discovered and widely applied
in vivo [101–103,112]. In much the same way that Green Fluorescent Protein(GFP)
has allowed momentous discoveries in protein biology and cellular processes [10,113],
these unique type of functional RNA promise to allow spatio-temporal detection
and mapping of RNA in vivo and unlock a new era in nucleic acid biology and
biotechnology.
1.6 Obstacles in Aptamer Development
Despite the discussed benefits of using nucleic acids and promises of amazing
functionality, aptamers are usually relegated to use in only a few niche applications
and have rarely found utilization outside of basic research. This lack of widespread
acceptance is generally attributable to 1) the limited chemical functionality of
nucleic acids and 2) the fact that conventional SELEX is time-consuming, labor-
intensive and often fails to produce aptamers with desirable functionality [29,34].
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1.6.1 Chemical Limitations of Nucleic Acids
Nucleic acids have inherently less chemical diversity than amino acids. For this
reason, it is thought that natural nucleic acids may never be able to reliably
address all possible targets and functions that proteins can. To confront this
limitation, many groups have successfully incorporated non-natural nucleobases,
backbones, sugars, and functional groups onto the nucleic acid scaffold in order
to achieve enhanced affinity, specificity, function, and stability [60–63,114]. While
this approach is a valid way of improving the chemical diversity of nucleic acids,
there is a limit to the types and extents of modifications that can be made due to
incompatibility of modified nucleotides with available biological machinery such
as polymerases [60,63,115]. While it is possible to evolve new enzymes that accept
these modifications [63,116], there does not exist a method of arbitrarily modifying
aptamers and assuring that they are compatible with available enzymes. For many
applications including in vivo uses [117], modified nucleic acids will likely remain
necessary for widespread adoption so development of new and improved in vitro
selection techniques that can readily incorporate new modifications remains a
priority. While improving nucleic acid functionality with chemical and enzymatic
modifications remains a topic of intense interest, this dissertation will not go into
extraordinary detail of how to approach these challenges.
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1.6.2 Inefficiencies in the SELEX Process
The SELEX process was a truly inspired discovery and has since allowed numerous
insights into the mechanisms and roles of functional nucleic acids. However, it is
not without issues.
Sequence Partitioning
Perhaps the most important step of SELEX is the efficient partitioning of
functional from non-functional sequences (Figure 1.2 Step 2). Usually, this is
performed by stringently washing away unbound sequences or those that do not
adhere tightly with the ligand of interest. In this step, only aptamers which are
tightly bound to the target survive and are chosen to undergo further rounds of
selection. While simplistic in nature, this process is implicated as the cause for
many of the problems that SELEX faces.
Under ideal equilibrium conditions, the likelihood that an aptamer remains
bound to its target (and is thus recovered for further rounds of SELEX) is dependent
on:
`b =
[T ]
[T ] +Kd
(1.1)
where `b is the likelihood that a described aptamer is bound to its cognate ligand,
[T ] is the concentration of available target, and Kd is the dissociation constant of
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the aptamer sequence with the target. Thus, every wash step in the partitioning
process assists in removing high Kd (low affinity) sequences but also has a stochastic
likelihood to remove the desired low Kd (high affinity) aptamers. For rare sequences,
this is especially troubling because the prospect that an individual aptamer sequence
remains is coupled to its representation (copy number) in a pool. Given that
high-performing aptamers generally have many distinct regions necessary for their
function [64], added functionality implies increased rarity in a random library. Thus,
the rarest (and potentially most functional) sequences have a tangible chance of
being irreversibly lost from the pool during this step.
In addition, SELEX methods reliant on equilibrium kinetics and partitioning
in this manner all suffer from a theoretical limit on how strongly a well-performing
sequence can be enriched relative to other, poorer-performing, sequences. Irvine
and others have shown that the theoretical maximum enrichment for a given
aptamer relative to another in the same round of SELEX, is equal to the ratio of
their Kd
[118–120]. Thus, successful enrichment of a high affinity aptamer is constantly
being impeded by low-affinity sequences that are more common. This means that
many rounds of SELEX are necessary to adequately enrich the highest affinity
binders such that they can be identified during sequence analysis. Many rounds
of selection inevitably lead to undesired biases in the process; such as the loss of
rare, high-performing sequences [121], PCR bias [122], and parasitic amplification of
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undesired sequences [118,119]. When compounded, these effects often lead to outright
failure or identification of sequences with only poor performance.
While separation based on tight target binding has proved to be an effective
way of finding aptamers for the purpose of target recognition (high affinity),
more complex functions such as structure switching, fluorescence enhancement,
target specificity, and catalysis are often identified only once the selection is
completed [53,108,110]. Because the partitioning process does not take into account
these higher-order functions, successful identification of functional aptamers is too
often reliant on chance rather than experimental rigor.
To achieve these functions, sequences must often undergo further design and
engineering after being discovered [123,124]. This can be done through incorporation
of exogenous nucleobases [125]; or by introducing regions which induce structure-
switching upon the addition of target ligands [104,123,126] or complementary oligonu-
cleotides [53,92,127]. Optimization processes such as these mean that the aptamer
discovery process does not end with sequence characterization and further work
is needed to incorporate new functions [51,101,128]. Because added work begets
added resources and costs, this process of rational design can be detrimental to
the widespread application of aptamers. To avoid this issue entirely, there is
growing interest in developing methods of directed evolution directly for aptamer
function [129,130].
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Sequence Analysis
Until recently, sequence analysis began with the identification of only a handful
(typically less than 100) sequences using Sanger sequencing. These were then
analyzed to identify conserved motifs indicative of their function. In comparison to
Sanger sequencing, high-throughput sequencing (HTS) has increased the number of
sequences which can be analyzed by several orders of magnitude (> 106 sequences)
and is readily available to researchers through commercial vendors or academic
facilities.
With the rise of HTS, it is becoming common practice to sequence every round’s
pool in a selection and analyze the resulting data using ever-more-functional
software [131–133]. This is done in order to identify sequences that are 1) highly
abundant, 2) exhibit a large increase in copy number over successive rounds
or 3) predicted to function based on sequence-structure motifs because these
sequences are most often the best-performing. Nonetheless, definitively identifying
the singular best sequence from the hundreds or thousands of unique sequences
resulting from HTS remains an unsolved issue.
Aptamer Characterization
Characterization is the bottleneck in many discovery processes because effective
high-throughput characterization methods are not widely accessible. Thus, only a
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handful of the sequences identified using HTS are usually subjected to rigorous
characterization. An ideal, high-throughput characterization method would be
done inexpensively (on a per-aptamer basis), using widely-available equipment and
reagents, and with a minimal amount of solution-phase target. Previously, this had
been done using custom DNA microarrays [134,135] on which thousands of aptamer
sequences are printed into ”colonies” in a uniform and defined manner. These
chips can then be incubated with various concentrations of fluorophore-labeled
target and the fluorescence of each colony can be correlated to binding performance.
However, array-based methods are limited by the number of sequences that can be
readily printed, and the length of DNA sequences that can be robustly synthesized
due to inefficiencies of the phosphoramidite chemistry used in their production.
These limitations have been largely addressed through a high-throughput char-
acterization method termed HiTS-FLIP [136]. This assay performs simultaneous
aptamer discovery and characterization on millions of DNA sequences simultane-
ously using modified HTS equipment. While not yet available to most researchers
through a commercial vendor or otherwise, this platform has since been expanded
to work with RNA aptamers [137,138] and promises to be a very effective method
for truly high-throughput RNA aptamer characterization. As an added benefit,
characterization directly using the chip on which a pool is sequenced means that
much of the guesswork required in identifying suitable candidates is removed.
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1.7 Incorporating Design and Bias to Improve
Directed Evolution
The limitations of SELEX are apparent when we compare the best in vitro selected
aptamers with functional sequences that have been evolved in natura. While
some RNA has been evolved to perform catalysis, their functionality is dwarfed by
that of RNA in the ribosome (containing ≈ 3− 7kilo-bases of RNA). Due to its
unfathomable theoretical complexity (> 43000) it is entirely implausible that the
ribosome was developed in loco, rather it was likely assembled piece-wise through
the random agglomeration of the many smaller, distinct catalytic RNAs that are
believed to have once made up the RNA world [139].
Towards the goal of discovering novel higher-order nucleic acid function, we can
mimic this natural piece-wise assembly. Indeed, there already exists an abundance
of aptamers against relevant and interesting targets including small molecules,
proteins, viruses, whole cells, tissues, and inorganic materials (See Section 1.3).
However, these aptamers are oftentimes less functional than desired due to poor
specificity, inadequate affinity, or lackluster performance [33]. While this problem
has lead to an abundance of new and better selection methodologies [64], it is rarely
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desirable to evolve a new aptamer or design a discovery method every time a new
application is explored.
Instead, a known aptamer can be modified to yield new or optimized perfor-
mance.This is usually done through two methods: 1) rational modification of
existing function from known aptamer motifs, or 2) biasing an aptamer pool to
explore nearby sequence space (i.e. a sequence/performance landscape).
Rational modification of known motifs can be used to explore function of
an aptamer by point- or segment-wise modification [136–138,140,141]. For example,
a natural guanine-specific riboswitch was found to switch specificity to adenine
on the basis of a single C to U substitution [142]. In general, the complexity of
any folding-binding relationship for an arbitrary nucleic acid currently exceeds
our rapid and accurate computational and design capabilities [143–145]. Thus, for
any given function, designing an optimized functional motif from first principles
is extremely difficult - and only becoming a more distant goal as we aim for
higher-order complexity.
Biasing a pool is usually done through pool mutagenesis [146,147] using methods
such as error-prone PCR [148] or random splicing/recombination of sequences in a
pool [149,150]. However, design principles can play roles in designing new random
libraries [151] for in vitro selection. For example, a library incorporating minimally-
conserved structural regions resulted in better-performing aptamers than when
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using a totally random library [152]. Thus, in many cases, it could be ideal to
develop a partially-designed random library around a known target aptamer and
perform a selection using the best available methodology so as to improve the
aptamer and incorporate additional function. However, this requires we move
beyond the inefficiencies of traditional SELEX.
1.8 Particle-based Display Methods To
Overcome SELEX Limitations
In 2014, Wang et. al presented a method termed particle display (PD) that promises
to revolutionize the discovery of aptamers [153]. Using this method, they were able
to reliably obtain aptamers against targets previously believed to be untargetable
using natural DNA aptamers [60], and with affinities rivaling or exceeding those of
the best available antibodies. The reason for this methods incredible success is
because of how it addresses many of the problems that riddle traditional SELEX.
1.8.1 The Particle Display Process
Particle display begins by transforming a solution-phase pool of random DNA
sequences into homogeneously-coated, monodisperse aptamer particles (APs, Figure
1.4). These APs display thousands of copies of a single DNA aptamer on the
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surface of paramagnetic, 1µm polystyrene beads. These are then incubated with
a solution-phase, fluorescently-labeled protein. Next, each AP is interrogated
using a Fluorescence-Activated Cell Sorter (FACS) which measures fluorescent
and light-scattering properties of individual particles and can separate them based
on parameters defined by their fluorescence signature. Thus, APs which exhibit
high fluorescence (indicative of target recognition) can be quickly and effectively
separated from non-fluorescent APs. Collected particles are then subjected to
amplification via PCR and the cycle repeats. Whereas traditional SELEX usually
requires 6-20+ rounds of selection, PD can reliably produce high-quality aptamers
in 3 rounds or fewer. This eliminates many of the biases associated with repeated
rounds of SELEX, and greatly improves the success rate of aptamer discovery.
1.8.2 Advantages of Particle Display
The reason that PD can reproducibly achieve aptamers with remarkable perfor-
mance is because it almost entirely removes the theoretical limit on enrichment
possible for a well-performing aptamer over its poorer-performing counterparts
during a single round of partitioning (as discussed on page 20). Whereas the
maximum enrichment of one sequence relative to another in SELEX is tied to the
ratio of their Kds, PD is capable of enriching sequences at levels that are orders of
magnitude more efficient (Figure 1.5). This is because each aptamer is present in
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Figure 1.4: Selection scheme using Particle Display (PD). Step 1: A random
pool of DNA is converted into monoclonal aptamer particles (APs) using emulsion
PCR. Step 2: Emulsions are broken, excess reagents are washed away, and the
complementary DNA strand is removed. Step 3: APs are incubated with a
fluorescently-labeled target Step 4: FACS is used to isolate fluorescent APs from
those with little or no fluorescent signal. Step 5: Collected APs directly undergo
PCR amplification. Steps 1-5 are repeated 2-3 times until pool converges to a
handful of functional sequences. Step 6: Pool undergoes sequencing and
candidate aptamers are characterized.
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huge populations that are individually characterized before being partitioned. In
this step, only functional populations that exhibit high target binding (indicated by
fluorescence response) are collected for the next round of PD. This is a remarkable
improvement over SELEX wherein the vast majority of retained sequences in the
early rounds of selection are weakly- or entirely non-functional.
PD also removes the uncertainty associated with equilibrium binding kinetics
common in traditional SELEX. When an aptamer is present in a single copy in
solution, the likelihood that it is bound is dependent on Equation 1.1. Thus, even
high-performing (low Kd) sequences have a non-zero chance of being irreversibly
lost from the selection. In PD, however, `b defines not the likelihood that an
aptamer is recovered during a round, but rather the fraction of aptamers displayed
on an AP that are bound to their target:
fb = N · lb = N · [T ]
[T ] +Kd
(1.2)
where N is the number of sequences expressed on the surface of an AP and is
on the order of ≈ 105 per AP. When an AP is measured using FACS, the mean
fluorescence signal is defined as:
F = (Fmax − Fbg) · fb + Fbg = (Fmax − Fbg) · N · [T ]
[T ] +Kd
+ Fbg (1.3)
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Figure 1.5: Maximum enrichment ratio possible for two sequences as a function
of the ratio of their Kd. PD exhibits orders of magnitude higher enrichment
potential, explaining how it is able to converge a pool to a small number of highly
functional sequences over the course of 2-3 rounds. Reproduced with
permissions [119].
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where Fmax is the maximum mean fluorescence of a particle saturated with target,
and Fbg is the mean background fluorescence due to non-specific target binding.
In PD, only particles which exhibit a fluorescence signal F greater than the
sorting threshold defined as Fmax/3 are collected. If a significant fraction (typically
considered as greater than 0.1%) of the APs surpass the sorting threshold, the target
concentration is reduced (Figure 1.4. Step 3) such that fewer APs fluoresce at levels
above background. Thus, rare, well-performing sequences can be greatly enriched
even in the presence of more abundant, low- or moderately-performing sequences
by simply adjusting [T ] such that the fluorescent signal for these undesirable
sequences falls below the sorting threshold.
Using this method, Wang et al. discovered DNA aptamers again 4 distinct
protein targets with Kd values ranging from 7pM to 2.3 nM
[119]. Interestingly,
three of these targets had been previously classified as ”untargetable” using natural
DNA aptamers [60].
In addition to these remarkable abilities, PD has been further modified to allow
selection of highly-specific DNA aptamers against protein targets. In 2017, Wang et
al. showed that by enriching for sequences in the presence of fluorescently-labeled
non-target proteins, aptamers can be discovered that show unrivaled specificity to
target proteins [154]. These sequences show better affinity and specificity in complex
environments (e.g. 10% human serum)than even the best commercially-available
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antibodies, and shows that PD-based methods of aptamer discovery can be used
for the direct, functional selection of incredibly well-performing aptamers.
1.8.3 Limitations of Particle Display
While particle display has exhibited some remarkable abilities to discover high-
performing aptamers, it suffers from two major drawbacks. First, PD is currently
only accessible for DNA-based selections. While there exists much debate over
the advantages and limitations of DNA [76], it is generally believed that RNA can
exhibit higher-order functionality due to the 2′-OH group and the more diverse
structures into which it can fold [155]. Additionally, RNA aptamers have direct
relevance in vivo because they can be expressed directly by cellular machinery
whereas single-stranded DNA aptamers cannot.
Secondly, the throughput of APs separable by FACS is on the order of 2× 107
per hour. Thus, the maximum number of sequences which can be exhaustively
measured in the first round of PD is ≈ 108. While this number could be improved
by 1-2 orders of magnitude through parallelization efforts over long time scales,
it is dwarfed by the number of sequences typically searched using traditional
SELEX (≈ 1014 sequences). As we look to push the limits of functionality and
find aptamers exhibiting ever-more-complex activity, it will become necessary
to perform PD-based selections using highly diverse libraries. Currently, this is
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addressed by performing a small number of SELEX rounds (typically 1-2 rounds)
prior to initializing PD. This helps reduce the diversity of a library to a number
more manageable by FACS without suffering the drawbacks associated with many
rounds of SELEX (see section 1.6). However, many issues remain with traditional
SELEX that lead us to prefer an exclusively particle-based selection technique.
1.9 Thesis Objectives
Aptamers have shown incredible functionality since their initial discovery in 1990.
However, many problems remain with traditional SELEX methodologies that
make them incompatible with desired functional selections or inefficient at reliably
discovering new aptamers against the plethora of interesting targets. As we begin
to require more complex and functional nucleic acids (such as fluorescence enhance-
ment or switching), directed evolution using traditional SELEX will continue to
lag behind our needs. Particle-display based methods have been shown to answer
many of the issues that SELEX encounters, but comes with its own drawbacks
including limited library size and lack of functional diversity. In this dissertation,
I summarize a series of projects towards addressing these remaining issues.
I explore the uses of a new, particle-based selection technique, termed GRAP
display, towards efficient discovery of functional RNA aptamers. Chapter 2 intro-
duces this new technique and shows how it can be used to discover highly-functional,
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unique, and applicable fluorescence-enhancing aptamers against the small molecule
dye malachite green.
Chapter 3 describes a method of addressing throughput limitations of particle-
based selection methods through incorporation of a known functional aptamer
motif. I show that, without the use of any traditional SELEX methodologies, I can
discover aptamers that outperform the best known fluorescence-enhancing aptamer
in terms of affinity and fluorescence enhancement. I also introduce a new method
of random library design that, coupled with GRAP display, could be applied to
maximally explore sequence space around known functional sequences.
Chapter 4 combines the topics put forth in Chapters 2 and 3 to show that
GRAP display can be used to discover structure-switching RNA aptamers through
the re-evolution of known motifs joined by a randomized transduction region. The
results of this selection show that GRAP display can discover switching motifs
beyond those that would be predicted using rational design. This selection is the
first step towards evolving modular aptamers of complex and arbitrary function.
Chapter 5 summarizes these results and briefly introduces possible directions
for further research towards functional and efficient aptamer selection.
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Chapter 2
Gene-linked RNA Aptamer
Particle (GRAP) Display
2.1 Introduction
Fluorescent proteins have an indispensable role in any biologists toolkit. This is
because these proteins allow an unparalleled view into the expression, localiza-
tion, and activation of cellular processes. Green fluorescence protein (GFP) [156]
is arguably the most famous fluorescent protein and has resulted in countless
discoveries, earning the founders of this protein the Nobel Prize in Chemistry in
2008 [113]. While a vast array of fluorescent proteins are available to researchers
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today [157,158], there exist very few methods of fluorescently-labeling a biomolecule
of equal importance: RNA.
GFP works through encapsulation of 4-(p-hydroxybenzylidene)imidazolidin-5-
one (HBI) [156], which is formed spontaneously from the tripeptide Ser65-Tyr66-
Gly67 [159]. In general, fluorescent proteins work through activation of an inter-
nalized, covalently-linked small molecule chromophore. (i.e. HBI) These chro-
mophores are non-fluorescent but become active upon correct folding of their
protein scaffold [160]. When excited with light at one wavelength, the encapsulated
chromophores fluoresce and emit light at a lower energy, red-shifted wavelength [16].
Because no sequence of natural RNA nucleotides is known to naturally fluoresce,
fluorescent RNA requires the addition and subsequent activation of an external
chromophore [13]. Thus, when we wish to image an RNA of interest, it is oftentimes
fused with a fluorescence-enhancing (FE) RNA aptamer that activates an externally-
applied chromophore. The target RNA can then be localized by detection of
the FE RNA aptamer. The Spinach aptamer [109], for example, enhances the
fluorescence of DFHBI (Figure 1.1) and has been used to image small-molecule
metabolites [101–103,161] and mRNA expression [112]; among other uses.
However, unlike fluorescent proteins, only a handful of FE RNA aptamers are
currently available [13]. This puts significant limitations on their utility in biological
research. This problem is a direct result of inefficiencies in the selection procedure,
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because SELEX enriches aptamers foremost on their ability to bind a target. It
is only after a selection is performed that these sequences can be tested for their
FE ability. Thus, the discovery process is inherently inefficient and low-yield.
For example, less than 1% of the aptamers discovered alongside RNA Spinach
produced any measurable fluorescence signal [109,110]. To compound issues, previous
selections have shown that the binding affinity of an aptamer correlates poorly
to the aptamers fluorescence enhancement capabilities [108,109]. For these reasons,
there is an unmet need for a selection method that can reliably and efficiently
produce fluorescence-enhancing aptamers based foremost on this ability. Successful
deployment of this method would enable accelerated discovery in nucleic acid
biology in a similar manner to what the widespread availability of fluorescent
proteins has done for protein biology [10,113].
Our lab has previously demonstrated the utility of particle-based display
methods for the selection of DNA aptamers using particle display (PD) against
fluorescently-labeled protein targets [119,154]. PD offers many advantages, such
as the ability to interrogate each aptamer sequence individually and efficiently
separate only those sequences with the desired functionality. Building off this work,
we wished to develop a particle-based display method for the expression of RNA
aptamers. We hoped to develop this method in order to take advantage of the
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many benefits of particle display (see Section 1.8.2), and to prove its usefulness by
selecting for a function which traditional SELEX has difficulty addressing.
To this end, we have developed Gene-Linked RNA Aptamer Particle (GRAP)
display to enable the screening of RNA aptamers directly for their ability to cause
FE of a small molecule chromophore - malachite green (MG). This is the first
in vitro selection methodology that allows high-throughput screening of RNA
aptamers based upon fluorescence performance rather than binding affinity. We
use this method to identify aptamers with higher affinity and quantum yield than
the best known fluorescence-enhancing aptamer. In addition, we show that this
method allows us to tune the emission profile of the selected aptamers, a first step
in being able to offer a palette of well-performing, fluorescence-enhancing (FE)
RNA suitable for biologists use.
2.2 Results and Discussion
2.2.1 Gene-Linked RNA Aptamer Particle (GRAP)
Display Process
In PD, 1 µm paramagnetic polystyrene beads are modified with a DNA primer
sequence to allow the display of covalently-linked, single-stranded DNA sequences.
In GRAP display (Figure 2.1), we modify these same 1 µm beads to incorporate an
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additional oligonucleotide which allows us to tether an RNA sequence to the bead
surface. Specifically, magnetic beads are functionalized with equivalent amounts
of a DNA forward primer and a poly-thymidine (poly-T) capture oligo which is
terminated with a 3′ inverted deoxythymidine to inhibit extension during PCR.
These beads then undergo an emulsion PCR process whereby the particles are
converted into monoclonal gene particles that each display thousands of identical
copies of a fluorescently-labeled DNA sequence on their surface. The DNA on these
particles remains double-stranded, and the beads are subjected to an additional
emulsion reaction under in vitro transcription conditions to yield a pool of GRAPs
(see Methods).
Upon breaking these emulsions and removing reaction byproducts, these parti-
cles are incubated with the non-fluorescent dye and a fluorescent signal for each
particle is obtained through FACS. If the fluorescence signal of a particle surpasses
the background fluorescence as described in Section 1.8.2, the FACS instrument
physically separates this particle from its non-fluorescent counterparts. Only these
collected particles are added to a polymerase chain reaction (PCR) mixture in
order to amplify the displayed DNA. Amplified DNA product is then used for
further rounds of GRAP display until no more enrichment is observed. Because we
are screening directly based on the fluorescent signal of an aptamer-chromophore
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Figure 2.1: Gene-linked RNA Aptamer Particle (GRAP) display. Step 1: A
random pool of DNA is converted into monoclonal gene particles using emulsion
PCR. Step 2: Emulsions are broken, excess reagents are washed away, and the
particles are re-emulsified with transcription reagents. Step 3: Emulsions are
cleaned and excess reagents removed. Gene-linked RNA Aptamer Particles
(GRAPs) are incubated with a non-fluorescent chromophore Step 4: FACS is
used to separate GRAPs with high fluorescence from those with no fluorescence.
Particles that do not bind or bind but do not enhance chromophore fluorescence
are not collected. Step 5: Collected GRAPs undergo PCR amplification. Steps
1-5 are repeated 2-3 times until pool converges to a handful of functional
sequences. Step 6: Pool undergoes sequencing and candidate aptamers are
characterized.
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complex, this method is effective at screening directly for FE aptamers where other
selection methodologies fail.
Enrichment is monitored by looking at the fraction of DNA-coated GRAPs that
surpass background fluorescence at a given target concentration. For subsequent
rounds, if there is no marked increase in the signal of beads surpassing the sorting
threshold (Figure 2.1, Step 4), the final pool is deemed converged. If, however,
more GRAPs surpass this threshold than in the previous round, an additional
round of screening is performed at a lower target concentration in order to increase
selection stringency. Once no further enrichment is observed over subsequent
rounds (which usually takes 2-3 rounds using GRAP display), all pools in the
selection undergo HTS.
2.2.2 GRAP Display Allows Fluorescence
Characterization of Individual RNA Aptamers
In contrast to conventional SELEX-style methods that enrich aptamers solely
based on binding, GRAP display allows us to profile and isolate aptamers directly
based on their fluorescent properties. The signal (Fλ) generated by a given aptamer
upon binding malachite green is determined by several aptamer properties.
For example, a high Fλ at a measured wavelength may arise because the aptamer
has a high quantum yield (high φF ), is highly occupied (low Kd), or because the
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excitation and emission profile results in many photons emitted at the measured
wavelength (high Sλ) upon excitation. Likewise, a low Fλ could result from low
quantum yield, poor affinity, or because the excitation or emission spectra falls
outside the excitation wavelength or emission channel. The relationship between
these various properties is described by the equation:
Fλ = φF · [T ]
[T ] +Kd
· Sλ (2.1)
where [T] is the concentration of malachite green.
In SELEX-style experiments, aptamers with high affinity (low Kd) for the
target molecule are preferentially enriched. This can lead to a selection failing to
yield suitably bright aptamers because mere binding to an aptamer is insufficient to
guarantee restriction of intramolecular rotation (RIR). By analyzing each aptamer
based on the properties described, we show that GRAP display can be used to tune
selections for fluorescence-enhancing aptamers based on their unique combination
of fluorescent properties.
2.2.3 Rationale for Choosing Malachite Green
We performed our first GRAP display selection using malachite green (MG). We
chose MG as our target for four reasons: i) MG undergoes fluorescence enhancement
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Figure 2.2: A) Chemical structure of malachite green (MG). When
unconstrained, the aromatic rings are able to rotate freely (red arrows). B)
Absorbance spectra of free MG. MG exhibits a maximum absorbance peak around
618nm ( = 148, 900M−1cm−1) [162]. C) Fluorescence emission spectra of
aptamer-bound MG. Upon binding to MGA, the fluorescence of the MG:MGA
complex (red) increases by about 2360-fold above MG in the unbound state (blue)
upon RIR (Figure 2.2 A), ii) The maximum absorbance band [152] is compatible
with the FACS laser used at 633nm (Figure 2.2 B), iii) MG in the unbound state
is very weakly fluorescence (Sunboundλ ) (Figure 2.2 C (blue spectra)), and iv) the
brightest-known fluorescence enhancing aptamer is against MG [55,107](Figure 2.2 C
(red spectra)). Thus, we wished to challenge our methods ability to find better
(brighter, higher affinity) aptamers than SELEX allows.
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2.2.4 GRAP Display Enriches for FE Aptamers with
Unique Fluorescent Properties
We began the GRAP display process by first performing two rounds of traditional
SELEX against MG in order to reduce the diversity in our pool to a size more
manageable by FACS (≈ 108 sequences). While SELEX has many disadvantages
and enriches based upon binding affinity rather than fluorescence enhancement,
many studies have shown that the early rounds of SELEX are efficient at enriching
towards functional aptamers without suffering from the biases that many rounds
of SELEX incorporates [132,163,164].
Prior to initializing the GRAP display process, we were aware that fluorophores
can adopt unique excitation and emission profiles dependent on their micro-
environment [16]. Also, previous selections have shown that a single chromophore
can produce distinct fluorescence profiles based on the aptamer sequence with
which it is bound [109]. Thus, we attempted to actively select for aptamers that
produced distinct emission profiles.
The partially-converged pool was converted into GRAPs through two consecu-
tive emulsion reactions. The resulting GRAPs express a functional RNA aptamer
and their fluorophore-labeled parent DNA. Next, we incubated these with 10
µm MG and collected all APs which exhibited fluorescence above background at
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wavelengths greater than MG’s primary excitation peak of 618nm (Figure 2.2 B).
Specifically, this entailed collecting particles from three sort gates: 670± 30nm,
730± 45, and 780± 60nm. Particles collected in these gates were combined and
underwent PCR in preparation for the next round of GRAP display.
Over the course of selection, the concentration of malachite green was reduced
from 10 µM at the start (Round 0), to 1 µM in Round 1, and 100 nM in Round 2
(Figure 2.3). The mean fluorescence intensity above background of the resulting
Round 3 GRAPs was dramatically improved over the Round 0 pool, as indicated
by the significantly higher fraction of particles meeting the sort gate threshold even
at a drastically lower target concentration (7.73− 14.3% in Round 3 compared to
0.03− 0.13% in Round 1). With the Round 3 GRAPs, no additional enrichment
was observed at concentrations below 100 nM.
In addition to greatly enriching for fluorescence-enhancing aptamers, we noticed
that the Round 3 pool had bifurcated into two distinct populations with separate
emission profiles. We partitioned the Round 3 pool into a blue-shifted (Round
3-B) pool and a red-shifted (Round 3-R) pool based upon the relative intensities
in the 670± 30nm and 780± 60nm channels(Figure 2.4).
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Figure 2.3: FACS summary of GRAP display process. We performed three
rounds of GRAP display and collected all events that exhibited a strong
DNA-fluorophore signal (y-axis) and fluoresced above background in the
670± 30nm, 730± 45nm, and 780± 60nm emission channels (x-axis). Particles
sorted in each channel were pooled before PCR amplification and the next round
of GRAP display. We observed no further enrichment in the Round 3 pool
compared to the Round 2 pool at concentrations below 100 nM malachite green.
As target concentration is reduced, the sort gate is shifted to the left in order to
account for reduced background fluorescence.
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Figure 2.4: FACS plots of the Round 3 GRAP pool. This pool was clearly
bifurcated into two populations exhibiting distinct emission profiles. Upon
separating with FACS, one pool (Round 3-B) exhibited a higher mean
fluorescence in the 670± 30nm channel, whereas the other pool (Round 3-R)
exhibited a higher mean fluorescence in the 780± 60nm channel.
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2.2.5 High-Throughput Sequencing Identifies Numerous
FE Aptamers
We next subjected each round to HTS and obtained 2.44.2x106 sequences from the
Round 2, Round 3, Round 3-B, and Round 3-R pools. To begin narrowing these
candidates to a number more suitable for detailed characterization, we counted and
recorded a reads-per-million (RPM) value for all sequences in each pool and chose
to characterize the union of the top five most represented sequences in the Round
3, Round 3-B, and Round 3-R pools. This comprised 5 sequences from Round
3, none from Round 3-B (they were identical to the five most abundance Round
3 sequences already chosen), and 3 sequences from Round 3-R (See Methods for
further explanation).
Next, we determined a fitness (i.e. enrichment: ratio of a sequences current
round RPM over its previous round RPM) value for all sequences that were
significantly represented in the raw sequencing data (greater than 20 copies). We
determined this value because previous studies have repeatedly shown that high
enrichment over a round of selection can be a better predictor of performance than
copy number alone [132,163,164].
Many high-fitness sequences in each round were self-similar except by a one- or
two-base point mutation, insertion, or deletion. For example, sequence R3-B-3
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differs from sequence R3-4 by a single point mutation. Relatedly, 95 of the top
100 highest-fitness sequences in the Round 3-B pool are highly sequence-similar
to R3-4 in the same manner. For this reason, we chose the top 5 (if available)
non-similar sequences from the Round 3, Round 3-B, and Round 3-R pools. In
total, this comprised 5 sequences from Round 3, 4 sequences from Round 3-B,
and 5 sequences from Round 3-R. In total, 22 unique sequences were identified
for further characterization (Table 2.1. See Table 2.4 in Methods for copy number
and fitness information).
2.2.6 Fluorescence Performance of Identified Aptamers
In recording the performance of these sequences, we wished to decouple RNA
concentration from binding affinity because a single RNA sequence can exist in
multiple distinct thermodynamically-stable structures [155,165]. Thus, the concentra-
tion of RNA is not always equal to the concentration of correctly-folded (active)
aptamer. For example, high concentrations of RNA can promote dimerization of
two otherwise incompatible RNA strands by promoting more interaction between
nearby strands.
For this reason, we set the concentration of RNA at 100 nM and performed
a titration of free malachite green from 10 nM to 10 µM. The fluorescence re-
sponse at each concentration was measured using a Tecan M1000 plate reader
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Name Sequence (5′→ 3′) of core region
Effect of
Poly-A Tail
R3-1 TGCACGGAGGCGCCTCTGGTCCTTAGTTTAATCCATAACG +
R3-2 TACAATCTCAGGTGCACCTTTAGACCACTGTGTCTCTACA o
R3-3 CTAGCTTCGAGTAACGAAACGCGTGAGGCTGCCCCGCTCC o
R3-4 AGTCTAGAGCGGGTACCTGTGCTGCAAATCTCCCGTCACT +
R3-5 GTCCCAAGGAGGTGGGTGGGTGGTGTCGACTCCTTTTCTT o
R3-6 GTGCCACCAGACTCACGCACTAGATCCGGCCGAGTAACGA -
R3-7 GTCCCAAGGAGGTGGGTGGGTGGTGTCGACTCCTTTTCTT -
R3-8 AGAAATTGTGTAAGACCTTATTGAATGAGGCGCAACTCGC -
R3-9 TACAATCTTAGGTGCACCTTTAGACCACTGTGTCTCTACA -
R3-10 CTAGCTCCGAGTAACGAAACGCGTGAGGCTGCCCCGCTCC -
R3-B-1 TTACAATACAAGTCTTCGAAGACTGAGTTTTCCATCTCCA +
R3-B-2 TTCATCAACATAGGAGTGGGAGGGGTAGCTAGGGCTCGTG +
R3-B-3 AGTCTAGAGCGGGTACCTGTGCTGCAAATCTCCCGTCATT -
R3-B-4 CCGGCGTACTACGCGTAACCATGATCCCCACTCTTGACTT -
R3-R-1 ATCGATTCAATGCCGCCAAGGGCTAGCCCGATCCATAACG o
R3-R-2 CGCGTGCAACAGGGCCCTGATCCAGCACTCACTTATAACG +
R3-R-3 TACAAGAGATTCAAGCGCACGGTCTTCCACACCCAACTCG +
R3-R-4 TGCACGGAGGGGCCTCTGGTCCTTAGTTTAATCCATAACG -
R3-R-5 ATCGATTCAATGCCGCCAAGGGCTGGCCCGATCCATAACG o
R3-R-6 CGCGCGGGTCTCGAGACCCTGAATCATTTCTCGAAAAACG +
R3-R-7 CGCGTCACCAGGGACACTCGGATCCACTCACATCATAACG o
R3-R-8 CGCGTGCAACAGGGCCTTGATCCAGCACTCACTTATAACG +
Table 2.1: 22 sequences were identified from HTS for further characterization.
The effect of the poly-A tail on each sequence was evaluated (’+’ means the
poly-A tail improves function, ’o’ means it has no effect on function, and ’-’ means
it has a negative effect on the aptamers function). Sequences were characterized
without a poly-A tail unless it was found to improve function. See Methods
Section 2.4.14 for further details. Sequence R3-7 differs from R3-5 by an A8’
deletion in the FP region and was characterized as such.
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and fit to Equation 2.1 (see Methods Section 2.4.8). For each sequence, we were
able to obtain a dissociation constant (Kd) and signal generated by the bound
chromophore:aptamer complex (Fλ) at saturation (`b ≈ 1).
We next calculated Sλ by integrating the corrected excitation and emission
spectra for each aptamer relative to MGA. We could then compare each aptamer
to MGA(φMGAF = 0.187
[55], 2360-fold fluorescence enhancement, SMGAλ = 1. See
Methods for sequence information) and obtain quantum yields from Equation 2.1:
F (λ)sat
F (λ)MGAsat
=
φF
φMGAF
· Sλ
SMGAλ
(2.2)
Rearranging:
φF = φ
MGA
F ·
SMGAλ
Sλ
· F (λ)sat
F (λ)MGAsat
(2.3)
The results are shown in Table 2.2.
Of the 22 sequences identified by HTS, only R3-3 exhibited no fluorescence.
Two sequences, R3-4 and R3-R-3 enhanced the fluorescence of MG, but perform
above the concentration range probed in our characterization. Despite these three
sequences, this is a dramatic improvement over previous selections where as little
as 1% of characterized sequences exhibited any measurable enhancement [110].
Interestingly, R3-3 differs from R3-10 by a single nucleotide point mutation
(Figure 2.5) yet has no measurable Kd or FE. This suggests either 1) the point
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Name Sλ Kd (nM)
Fluorescence
Enhancement
(fold increase)
R3-1 1.05 2017.9 ± 167.6 110.7
R3-2 0.88 42.7 ± 12.2 19.2
R3-3 n.d n.d n.d
R3-4 n.d n.d n.d
R3-5 0.87 92.6 ± 22.4 49.7
R3-6 1.17 111.6 ± 12.0 259.4
R3-7 0.87 125.8 ± 34.6 42.3
R3-8 0.98 29.3 ± 8.4 17.7
R3-9 0.88 38.6 ± 10.7 37.9
R3-10 1.13 220.4 ± 39.2 317.5
R3-B-1 1.11 320.8 ± 26.7 619.5
R3-B-2 1.11 144.9 ± 26.3 494.9
R3-B-3 1.24 2094.6 ± 347.3 219.2
R3-B-4 1.15 579.3 ± 75.5 4273.3
R3-R-1 1.05 1301.9 ± 345.1 275.1
R3-R-2 1.05 1549.1 ± 441.8 238.2
R3-R-3 n.d n.d n.d
R3-R-4 1.05 1045.2 ± 124.6 189.2
R3-R-5 1.05 1488.7 ± 370.4 78.7
R3-R-6 1.05 1827.3 ± 175.6 147.9
R3-R-7 1.05 1561.7 ± 221.5 198.4
R3-R-8 1.05 1590.7 ± 227.0 237.3
MGA 1.00 61.0 ± 13.4 2360.0
Table 2.2: Characterization results of identified sequences. An area scaling
constant (S(λ)) was determined by integrating the corrected excitation and
emission spectra of each sequence, relative to MGA. Equations 2.1 and 2.3 were
used to calculate the Kd and fluorescence enhancement of each aptamer over
background. These values assume perfect folding of all sequences, so may differ
depending on the manner of determining Kd.
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Figure 2.5: Predicted secondary structure of sequences R3-3 and R3-10 using
mfold software [166,167]. These sequences differ from each other by a single
mismatch, yet the activity of R3-3 is not detectable (n.d.) suggesting the binding
pocket is inactive. We hypothesize this to be a result of the C→U mutation
causing base slippage and resulting in a more stable structure that disrupts the
binding pocket for this aptamer.
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mutation destabilizes the binding pocket, or 2) the nucleotide is responsible for
interacting with MG. Based on the predicted mfold [166,167] structures, this mutation
results in a significant change in structure. Thus, it seems likely that the reason
for reduced activity is due to destabilization of the active motif. Further studies
into this drastic change in fluorescence enhancement could have implications in
the design of structure-switching FE RNA considering R3-10 is highly functional
yet seems to be near a metastable equilibrium.
Sequences R3-2, R3-8, and R3-9 exhibited higher affinity than MGA. This
is especially impressive due to MGA(reported Kd = 117 nM
[55], measured Kd =
61.0±13.4 nM) having an already extremely high affinity in comparison to other
small-molecule aptamer which usually have dissociation constants in the µM range.
Further optimization of these sequences to yield improved φF could be useful
for in vivo or single-molecule imaging of RNA considering the high non-specific
background and cytotoxicity of MG at high concentrations. Binding isotherms
and dissociation constants of the highest affinity (R3-8), brightest (R3-B-4), and
most abundant (in the Round 3 and Round 3-R pools, R3-1) sequences are plotted
alongside MGA in Figure 2.6.
From the characterized sequences, only R3-B-4 was measured to be brighter
than MGA - exhibiting an 81% increased fluorescence enhancement. This is
notable because R3-B-4 was measured to have a Kd of 579 ± 76nM which is
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Figure 2.6: Measured dissociation constants for select sequences alongside
MGA. R3-8 represents the lowest Kd measured, Sequence R3-B-4 represents
the brightest aptamer discovered, and Sequence R3-1 was the most abundant
aptamer in the Round 3 and Round 3-R pools. Measurements were performed at
100 nM RNA.
nearly 10-fold higher (lower affinity) than MGA. We confirmed this quantum yield
measurement with the technique previously described [55]. After performing an
RNA titration at 500 nM malachite green, we obtained a φF for R3-B-4 of 0.348
(Figure 2.7 B). This yields a fluorescence enhancement of 4390-fold, nearly identical
to that obtained using the malachite green titration. Interestingly, using an RNA
titration yielded a dissociation constant around 10-fold higher than measured using
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Figure 2.7: Sequence R3-B-4 exhibits a higher quantum yield under two
different assay conditions compared to the brightest known fluorescence-enhancing
aptamer in literature MGA. A) Performing an MG titration with R3-B-4
resulted in a quantum yield of 0.339 (FE = 4270-fold) based on relative
fluorescence to MGA. Measurement was performed at 100 nM RNA. B)
Performing an RNA titration confirmed the reported quantum yield of 0.187 (FE
= 2360-fold). Sequence R3-B-4 was measured to have a quantum yield of 0.348
(FE = 4390-fold). Measurement was performed at 500 nM MG.
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a MG titration. We believe this results from stabilized dimerization of R3-B-4
resulting in a reduced folding efficiency. Because φF is measured in this assay
under conditions of limited dye, the disparity in measured Kd should have no effect
on the accuracy of the determined quantum yield.
Across all characterized aptamers, there exists little correlation between bind-
ing affinity and fluorescence enhancement ability. Likely, this is because FE is
dependent on certain binding modes which can each span a range of Kd values.
This emphasizes that affinity-based SELEX methods for identifying FE aptamers
can yield aptamers of sub-optimal functionality. For example, a sequence such as
R3-B-4 would likely be lost over many rounds of SELEX due to competition by
dimmer but higher-affinity sequences (e.g. sequence R3-8). This is because, in
SELEX, FE aptamers are enriched based on an unrelated property of the aptamer
(low Kd). On the other hand, GRAP display can gear the selection towards identi-
fying aptamers with both of these properties through reducing target concentration
(selection for high affinity) or by increasing the fluorescence threshold that triggers
sorting (selection for high FE).
This ability is well demonstrated by plotting the brightness and Kd of all
sequences (Figure 2.8). We see that high affinity, low-brightness sequences (which
would quickly come to dominate a pool using traditional SELEX) exhibit negative
enrichment from Round 3 to Round 3-B and Round 3-R. For example, Sequence
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Figure 2.8: Plotting the dissociation constant and FE of each aptamer shows
that GRAP display can effectively enrich sequences that would otherwise be lost
with traditional SELEX. We see that many high affinity sequences are negatively
enriched (unfilled shapes) going into the Round 3-R (red diamond) and Round
3-B (blue square) pools. In SELEX, these high affinity sequences would continue
to dominate a pool regardless of their FE performance.
R3-5, which represents approximately 10% of the Round 3 pool, experiences a
55-fold reduction in copy number in Round 3-R and 13-fold reduction in copy
number in Round 3-B, despite being of high affinity (Kd = 92.6 nM).
2.2.7 Direct Selection of Unique Fluorescence Profiles
It has been shown that different fluorophores can exhibit distinct emission profiles
upon binding the same dye target [16,109]. We were able to use GRAP display
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to actively select for aptamers based on the profiles they emitted. To do this,
we collected all fluorescing particles above the primary excitation peak of MG
(618nm) over the first two rounds of selection. Then, in Round 3, we plotted the
fluorescence signals generated across two distinct emission wavelengths (670±30nm
and 780±60nm) which were then sorted into blue-shifted (Round 3-B) and red-
shifted (Round 3-R) subpopulations (Figure 2.4).
Characterization of these pools confirmed that GRAP display allows us to
isolate aptamers that generate multiple distinct emissions profiles upon binding to
the same dye. While we initially expected to identify only two distinct profiles
between the Round 3-B and Round 3-R pools, we instead found that the aptamers
could be grouped into a total of 11 unique spectral families based upon their shared
excitation and emission profiles (Table 2.3).
As expected from the varied FACS plots (Figures 2.3 and 2.4), we measured
the excitation and emission profiles for all sequences in Round 3 and found the
emission maxima spanned a wide range of wavelengths (from 649nm 675nm).
Upon separating Round 3, however, we see that the sequences positively enriched
in Round 3-B have a much narrower range of emission maxima (649 654nm).
Likewise, all positively-enriched sequences in Round 3-R share a unique red-shifted
emission maximum at 675nm. The excitation and emission spectra for the most
59
Name
λexc
(nm)
λem
(nm)
Spectral
Family
R3-1 646 675 1
R3-2 641 669 2
R3-3 634 652 3
R3-4 631 649 4
R3-5 635 658 5
R3-6 633 651 6
R3-7 635 658 5
R3-8 628 651 7
R3-9 641 669 2
R3-10 634 652 3
R3-B-1 631 650 8
R3-B-2 634 652 9
R3-B-3 631 649 4
R3-B-4 636 654 10
R3-R-1 646 675 1
R3-R-2 646 675 1
R3-R-3 636 656 11
R3-R-4 646 675 1
R3-R-5 646 675 1
R3-R-6 646 675 1
R3-R-7 646 675 1
R3-R-8 646 675 1
WG 634 653
Table 2.3: Excitation and emission spectra were measured for the 22
characterized sequences and the maximum wavelengths for each recorded.
Spectral Family 1 exhibited the highest red-shifted emission, as expected from
this family’s high representation and enrichment in the Round 3-R pool.
Fluorescence from sequence R3-3 was observable with the spectrophotometer used
and is thus recorded.
60
Figure 2.9: Excitation (dashed) and emission (solid) spectra of selected
sequences. R3-4 (blue) is the most abundant sequence in the Round 3-B pool,
while R3-1 (red) is the most abundant sequence in the Round 3-R pool. These
sequences also represent the furthest blue- and red-shifted emission profiles of any
discovered. For comparison, MGA (black) is plotted.
abundant sequences in the Round 3-B and Round 3-R pools are shown in Figure 4
alongside MGA.
Upon inspection with mfold software, we predicted that the 675nm emission
spectra shared by members of Spectral Family 1 was because of a conserved
motif among these sequences. We performed minimization experiments around a
predicted hairpin and discovered a short, 15-nucleotide (nt) motif was responsible
for the unique red-shifted fluorescence spectrum(tR3-R, Figure 2.10). To our
knowledge, this is the shortest FE motif described in literature. Short motifs
are advantageous for in vivo tagging of RNAs that might not tolerate a larger
RNA tag. Based on the presence of this motif, we expect that 98 out of the top
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100 most enriched sequences in the Round 3-R pool share this same spectrum,
exemplifying the abilities of GRAP display to differentiate aptamers based upon
their fluorescence emission spectrum.
2.2.8 In Vivo Expression of Aptamers in Mammalian
Cells
Malachite green is regarded to be highly cytotoxic [168–170] and has been shown to
fluoresce brightly and non-specifically in vivo due to intercalation into the cell
wall [109]. However, an esterized variant of malachite green (MG-e, Figure 2.11 A)
is known to be membrane-permeable and has been successfully used for in vivo
imaging [171]. We performed a screen of our aptamers against MG-e and found that,
while most sequences exhibited minimal or no FE of MG-e, those containing the
tR3-R motif exhibited significantly increased fluorescence with MG-e compared to
the same concentration of MG(Figure 2.11 B). Due to its improved FE with MG-e,
we wished to express the tR3-R motif in cells to demonstrate that aptamers
selected using GRAP display can successfully be applied in vivo.
Previously, Filonov et al. had found that the tRNA aptamer scaffold [172] is
rapidly targeted for degradation by endonucleases [173] in mammalian cells. For this
reason, they adapted a previously known RNA three-way junction scaffold to more
stably express RNA aptamers in vivo. With the re-engineered F30 scaffold, they
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Figure 2.10: Minimum motif responsible for emission at 675nm. A truncation
experiment was performed at 200 nM RNA and 1µM MG for each motif by
pair-wise deletion in the hairpin. Shown in green is the motif (tR3-R) necessary
for FE of MG. To our knowledge, this represents the shortest fluorescence
enhancing motif described in literature.
showed stable expression of Broccoli-tagged RNA in HEK293T cells. Additionally,
incorporating more than one Broccoli motif into the scaffold yielded a substantial
increase in fluorescence compared to a single Broccoli motif. We wished to adapt
this scaffold for our use and so we incorporated 3 copies of tR3-R into the F30
scaffold (Figure 2.11 C). Next, we transfected the resulting F30-3x-tR3-R motif
into HEK293T cells using the pAV U6+27 plasmid (See Methods).
We confirmed expression of our transcript using flow cytometry by observing a
≈ 40% increase in the mean fluorescence of the transfected (containing F30-3x-tR3-
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Figure 2.11: A) Chemical structure of malachite green ester (MG-e). MG ester
(MG-e) is known to be membrane-permeable and suitable for in vivo fluorescence
imaging. B) While many sequences such as R3-B-4 exhibited significantly
decreased activity with MG-e compared to MG, sequences such as R3-R-7
(which contains the tR3-R motif) from the Round 3-R pool exhibited
significantly increased activity. Measurements were performed at 400 nM RNA
and 1M MG or MG-e. C) The predicted secondary structure of the F30-3x-tR3-R
transcript showing the three tandem tR3-R repeats. D) F30-3x-tR3-R enhances
the fluorescence of cells. Flow cytometry analysis shows ≈40% increased
fluorescence between transfected (blue) and untransfected (red) cells at
concentrations above 1.25M. 30,000 events were recorded at all concentrations.
R) versus the untransfected cell lines at concentrations above 1.25 µM (Figure 2.11
D). This data suggests that, given a suitable scaffold, aptamers selected in vitro
against a suitable dye target could be readily applied in vivo. Future selections
could benefit by performing the selection directly against a suitable cell-permeable
dye that exhibits low non-specific fluorescence in vivo.
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2.3 Conclusion
Fluorescent proteins are immensely important in cellular biology and their discovery
remains an active field of research. However, there exist very few methods for
detecting an equally important biomolecule: RNA. One common method involves
tagging an RNA of interest with a FE aptamer that activates fluorescence of
a non-fluorescent chromophore. However, very few FE aptamers exist that can
operate in this capacity. This is because the method of discovering FE aptamers
relies on enriching for sequences based on their binding affinity to the target
chromophore. which is a poor method of discovering new fluorescence enhancing
aptamers because the FE abilities of many discovered aptamers is found to correlate
poorly with binding affinity [108,109]. Thus, a new manner of aptamer discovery that
allows selection based on both binding affinity and fluorescence enhancement is
needed.
Gene-linked RNA Aptamer Particle (GRAP) display answers this need while
also providing a number of advantages over other selection methodologies. By
selecting for fluorescence abilities rather than strictly binding affinity, GRAP
display allowed us to discover the brightest fluorescence-enhancing aptamer known
even though the sequence exhibits significantly lower binding affinity than other
aptamers in the pool. Perhaps most interesting was the ability to isolate a
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population of red-shifted fluorescence-enhancing aptamers and identify a short,
15nt RNA motif responsible for the shared emission profile. The ability to ”tune”
the fluorescence of resulting aptamers would be of great use in developing a catalog
of aptamers yielding unique fluorescence profiles and based upon a small number
of related chromophore dyes.
We show that by directly selecting for fluorescence rather than binding affinity,
we can isolate RNA aptamers that are considerably more functional than MGA
after just three rounds of screening. Importantly, we demonstrate that we can
measure the fluorescence signal of every GRAP across multiple emission windows,
enabling us to directly identify aptamers on the basis of their spectral emission.
We believe the versatility of this method and applicability towards any suitable
fluorescent target should greatly expand the toolbox of reagents available for
studying functional RNA.
2.4 Methods
2.4.1 Immobilization of malachite green
We immobilized malachite green (MG) isothiocyanate (Molecular Probes) on the
surface of 2.7 µm Dynabeads M-270 amine beads (Invitrogen). The beads were
activated in 100 mM NaHCO3 buffer, pH 8.5, and suspended in 100 mM NaHCO3
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buffer, pH 9. MG isothiocyanate was added to the beads at a final concentration of
500 µg/mL and incubated with rotation overnight. The supernatant was removed
and the beads were washed thoroughly using dimethyl sulfoxide (DMSO, Fisher
Scientific) with gentle heating to remove free MG. Washing was repeated ≈10
times until no visible color change of the DMSO was observed. After washing,
the beads were visibly darkened, indicating successful functionalization though no
quantification was possible. Washed beads were suspended in TNaTE buffer (10
mM Tris pH 7.5, 150 mM NaCl, 0.01% Tween-20, 0.1 mM EDTA) and stored at
4◦C.
2.4.2 DNA preparation
The single-stranded DNA library and all primers used were synthesized by Inte-
grated DNA Technologies. Modified oligos were purified using HPLC, while all
others underwent standard desalting. Randomized bases were hand-mixed at a
25:25:25:25 ratio. The DNA library (Library) consisted of molecules containing a
randomized 40nt region flanked by conserved PCR primer-binding sequences. The
reverse primer (RP) was purchased alongside a 25-nt poly-T tail (RPpT) at the 5′
end for use with PCR and emulsion PCR, respectively. The forward primer (FP)
contained a T7 promoter region to allow transcription of the expressed aptamers.
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To functionalize carboxylic acid beads with primer, we purchased FP and the
25nt poly-T capture strand featuring a 5′-amino modification separated from the
first nucleotide by a 72-atom internal spacer (AmM-FP, AmM-pT). We purchased
a FAM-labeled FP complementary sequence (FAM-FPc) and FAM-labeled poly-A
(FAM-pA) to determine the extent of primer expression on the bead surface. We
also purchased a FAM-labeled poly-T RP (FAM-RPpT) for use with 1 cycle of
PCR to fluorescently-label the displayed DNA after emulsion PCR cleanup. We
purchased an Alexa Fluor 647-labeled FP (647-FP) to determine extent of RNA
coating upon emulsion transcription. The methods by which these processes were
performed, and the sequences for ordered oligos are given below.
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Oligo Sequence (5′→ 3′)
Library TAATACGACT CACTATAGGG ACACAATGGA CGNNNNNNNN
NNNNNNNNNN NNNNNNNNNN NNNNNNNNNN NNTAACGGCC
GACATGAGAG
FP TAATACGACT CACTATAGGG ACACAATGGA CG
RP CTCTCATGTC GGCCGTTA
RPpT TTTTTTTTTT TTTTTTTTTT TTTTTCTCTC ATGTCGGCCG TTA
FAM-RPpT /56-FAM/-TTTTTTTTTT TTTTTTTTTT TTTTTCTCTC
ATGTCGGCCG TTA
AmM-FP /5AmMC6//iSp18//iSp18//iSp18//iSp18/-TAATACGACT
CACTATAGGG ACACAATGGA CG
AmM-pT /5AmMC6//iSp18//iSp18//iSp18//iSp18/-TTTTTTTTTT
TTTTTTTTTT TTTTT
647-FP /5Alex647N/-TAATACGACT CACTATAGGG ACACAATGGA CG
FAM-FPc /56-FAM/-CGTCCATTGT GTCCCTATAG TGAGTCGTAT TA
FAM-pA /56-FAM/-AAAAAAAAAA AAAAAAAAAA AAAAA
2.4.3 Coupling forward primer to particles
500 µL of 1 µm MyOne carboxylic acid beads (Life Technologies,1010/mL) were
activated by washing once with 500 µL of 0.1 M NaOH and five times with
500 µL ddH2O. The beads were incubated with 1X conjugation buffer (200 mM
NaCl, 100 nM imidazole in water), 100 µM AmM-FP, 100 µM AmM-pT, and 250
mM 1-ethyl-3-(3-diemthylaminopropyl)carbodiimide (EDC) in 50% v/v DMSO
overnight at RT with rotation. The beads were then washed twice with 500 µL 0.1
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M 2-(n-morpholino)ethanesulfonic acid (MES) buffer (100 mM, pH 4.7) (Pierce
Biotechnology) for 10 minutes with rotation and resuspended in MES buffer.
To passivate unreacted functional sites, we converted unreacted carboxyls into
amino-reactive NHS-ester groups in the presence of 250 mM EDC and 100 mM
N-hydroxysuccinimide (NHS) suspended in MES buffer for 30 minutes. The beads
were conjugated with 20 mM amino-PEG12 in MES buffer for one hour. The
FP-modified beads were then washed two times with TT buffer (0.05% Tween-20,
50 mM Tris, pH 7.5) for 5 minutes to quench the reaction, resuspended in 500 µL
TNaTE buffer, and stored at 4 ◦C.
To test conjugation efficiency, we incubated two separate batches of 0.2 µL of
FP beads with 1 µM FAM-FPc and 1 µM FAM-pA, respectively, in 100 µL TNaTE
buffer at RT for 5 minutes. Each batch of beads was washed once with 100 µL
TNaTE buffer, and analyzed using a BD FACSVerse cytometer (BD Biosciences).
To confirm that the FP beads were suitable for PCR, we performed 20 cycles of
PCR with 1 µM FP, 1 µM FAM-RPpT, 1 nM template DNA, 1X GoTaq PCR
Master Mix (Promega), and 1 µL FP beads in 20 µL total volume. These beads
were then washed three times using 100 µL 100 mM NaOH, and washed once with
100 µL TNaTE buffer. These beads were resuspended in 100 µL TNaTe buffer
and analyzed on the FACSVerse. Generally, the fluorescence signal after PCR
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was ≈10-fold lower than for the primer conjugation efficiency test described above
which we suspect is a result of steric interference on the surface of these beads.
2.4.4 RNA library pre-enrichment
We PCR amplified 1x1014 sequences of the starting library with 1 µM FP, 1 µM RP,
and 1X Master Mix to prepare a double-stranded library for use in transcription. To
minimize PCR bias, we performed only 6 cycles of PCR on a total volume of 8 mL.
We performed PCR with the following conditions: 98 ◦C for 2 minutes, followed by
6 cycles of 98 ◦C for 15 seconds, 57 ◦C for 30 seconds, and 72 ◦C for 30 seconds. The
DNA was separated from the reaction mixture using phenol:chloroform extraction
and the aqueous phase was concentrated via butanol extraction. The recovered
DNA was ethanol precipitated using 2.75 volumes of ethanol and 0.1 volume 3 M
sodium acetate (pH 5.5), and resuspended in TE (10 mM Tris, 0.1 mM EDTA,
pH 7.5) buffer.
Transcription of 8x1014 of these DNA sequences was performed in five reac-
tion volumes with the TranscriptAid T7 High Yield Transcription Kit (Thermo
Scientific), following the manufacturers protocol. After DNase treatment for 1
hour at 37 ◦C, the recovered RNA was purified using a 6% urea-TBE acrylamide
gel (National Diagnostics), cut from the gel by UV shadowing, and recovered
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through the crush-and-soak method in water. The eluent was ethanol precipitated
as described above, and the recovered pellet was suspended in TE buffer.
In the first round of SELEX, we heat denatured ≈1x1015 RNA molecules
for 5 minutes and quickly placed on ice to cool. The RNA was incubated with
≈ 109 MG-coated beads in PBSMT buffer (1X PBS pH 7.4, 5 mM MgCl2, 0.01%
Tween-20), washed two times with PBSMT, eluted using PBSMT buffer heated to
95 ◦C, and reverse-transcribed using cloned AMV reverse transcriptase (Invitrogen)
following the manufacturers instructions. We amplified the recovered DNA using
PCR and transcribed into RNA as described above for use in a second round of
pre-enrichment. In the second round of SELEX, we reduced the amount of RNA
and target, using 4.5x1014 RNA sequences and 6.5x107 MG-coated beads.
2.4.5 GRAP synthesis
We generated our GRAPs using emulsion PCR followed by emulsion transcription.
The oil phase in both reactions consisted of 95% mineral oil, 4.5% Span 80, 0.45%
Tween 80, and 0.05% Triton X-100. For emulsion PCR, the aqueous phase consisted
of 1X PCR Master Mix (Promega), 10 nM FP, 1 µM RP-polyT, ≈ 108 beads,
and 1.5 pM template DNA. Water-in-oil emulsions were generated for emulsion
PCR by adding 1 mL of the aqueous phase to 7 mL of oil phase in a DT-20 tube
(IKA), which was locked into an Ultra-Turrax Device (IKA). The addition was
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performed drop-wise over 30 seconds while being stirred at 620 rpm for 5 minutes.
We performed emulsion PCR under the following cycling conditions: 95 ◦C for 5
minutes, followed by 40 cycles of 95 ◦C for 30 seconds, 57 ◦C for 60 seconds, and
72 ◦C for 60 seconds.
After PCR, the emulsions were collected into an emulsion collection tray (Life
Technologies) through brief centrifugation. The emulsions were broken using 3
mL of 2-butanol and transferred to a 50 mL tube. The particles were pelleted
by centrifugation at 4,000 x g for 5 minutes and the supernatant was decanted.
The particles were resuspended in emulsion breaking buffer (BB) (100 mM NaCl,
1% Triton X-100, 10 mM Tris-HCl, pH 7.5, and 1 mM EDTA) and transferred to
a 1.5 mL tube. The beads were sonicated, vortexed, centrifuged for 15 seconds
at 13,000 x g and placed in a magnetic separator (MPC-S, Life Technologies).
The supernatant was removed via pipette and the beads were washed once with
100 µL PBS, once with 100 µL BB, and three times with 100 µL 100 mM NaOH
to generate ssDNA and remove non-covalently bound DNA. We confirmed that
20±10% of the particles contained DNA by annealing ≈50,000 beads with 1 µM
FAM-RP-poly-T at RT for 5 minutes. The particles were washed once with 200
µL PBS-T and analyzed using the FACSVerse (BD Biosystems).
To generate double-stranded DNA on the particles, we subjected them to one
cycle of PCR using 1X GoTaq PCR Master Mix and 1 µM FAM-labeled poly-T
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RP. The beads were washed twice with 100 µL BB and resuspended in 500 µL
TNaTE.
Emulsion transcription was performed using the T7 High Yield Transcription
Kit. The aqueous phase consisted of 0.4X TranscriptAid Reaction Buffer, 4 mM of
each rNTP, 5 mM MgCl2, ≈ 5x107 DNA-coated beads/mL, and 0.4X TranscriptAid
Enzyme mix. For the starting (Round 0) pool, we used 1 mL of aqueous phase
and 7 mL of oil phase, and the emulsions were prepared in the UltraTurrax
device as described for the emulsion PCR process. In every subsequent emulsion
transcription reaction (Rounds 1-3), the emulsions were made in quadruplicate
through drop-wise addition of 50 µL aqueous phase over 15 seconds to 450 µL oil
phase in 2 mL cryogenic vials (Corning), which were being mixed at 1000 rpm by
Teflon flea micro stir bars (Fisher). The reaction vials were stirred for 3 minutes,
then incubated at 37 ◦C for 6-10 hours.
The emulsions were kept on ice and broken using 3 mL of cold 2-butanol and
transferred to a centrifuge tube. The particles were pelleted by centrifugation at
4◦C and the supernatant was decanted. The particles were then resuspended in
cold BB and transferred to a 1.5 mL tube. The particles were sonicated, vortexed,
centrifuged for 15 seconds at 13,000 x g, and then placed on an MPC-S. The
supernatant was removed by pipette. Further wash steps were performed without
centrifugation using cold BB, until all oil in the supernatant was removed. To
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confirm that the particles contained RNA, we incubated ≈50,000 GRAPs with
1µM 647-FP at RT for 5 minutes, washed once using 100 µL TNaTE, and analyzed
with the FACSVerse cytometer.
2.4.6 FACS screening
Prior to screening, we incubated FP beads with malachite green (Spectrum Chemi-
cal) at concentrations ranging from 10 nM to 10 µM in PBSMT pH 7.4 to determine
levels of background and non-specific binding. This is an appropriate baseline,
because ≈80% of particles after ePCR contain no PCR product and thus little to
no RNA, making them indistinguishable from FP beads. We performed FACS
on the Aria II instrument (BD Biosystems), isolating particles that exhibited a
fluorescence signal above background (defined as the sort gate) due to MG activa-
tion and which also exhibited a strong fluorescence signal from the FAM-labeled
dsDNA. This ensured that only particles which expressed both RNA and its parent
DNA were collected and enriched.
We incubated ≈ 108 particles in round 1 and ≈ 107 particles in all later rounds.
In each round, we performed a similar MG titration as described for FP beads above,
and chose an MG concentration such that ≈ 0.1% of the total population fluoresced
in the reference gate. All incubations were performed at a bead concentration such
that ≈ 5, 000 events/second were registered on the FACS instrument. Because of
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our interest in aptamers that cause MG to fluoresce at different wavelengths upon
excitation, we set reference gates for the following bandpass filters: 670±30nm,
730±45nm, and 780±60nm. We collected any events that fluoresced higher than
the background signal, which was established as described above, and the sorted
particles were directly added to a PCR mixture and amplified for use in later rounds.
Over the course of two additional rounds of selection, the MG concentration was
decreased 100-fold. After the second round of selection, we observed no further
enhancement in binding ability of the Round 3 pool at 10 nM MG. We then
separated the R3 pool into R3-B and R3-R pools by incubating the beads at a
concentration of 1 µM MG, separating using the FACS instruments, and PCR
amplified as described.
Channel: 670±30nm 730±45nm 780±60nm
Round 1: 6,646 6,713 4,946
Round 2: 7,532 5,536 5,210
Round 3: 21,332 18,795 18,640
Round 3-B: ≈20,000 0 0
Round 3-R: 0 0 ≈20,000
2.4.7 Sequencing analysis
High-throughput sequencing was performed at the Stanford Functional Genomics
Facility (SFGF) using the MiSeq sequencer (Illumina). Using a custom MATLAB
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script implementing the Bioinformatics Toolbox, the sequence data was analyzed
to obtain copy numbers of all sequences. For all sequences that were present in
>20 copies in the raw sequencing data, we calculated the reads-per-million (RPM).
The RPM was then used to calculate a sequence ”enrichment” value. Enrichment
is defined as the fractional increase in copy number relative to the previous round.
Thus, a sequence that went from 100 RPM in the Round 2 pool to 500 RPM
in the Round 3 pool would have an enrichment value of 5 in the Round 3 pool.
Enrichment values were only calculated for sequences with >200 copies in the
current round.
We chose to characterize the union of the top 5 sequences by RPM, and the
top 5 sequences by enrichment for each pool. In total, 22 unique sequences were
identified in this manner: 10 in the Round 3 pool, 4 in the Round 3-B pool, and 8
in the Round 3-R pool. The DNA sequences containing T7 promoter regions on the
5′ end were synthesized at Stanfords Protein and Nucleic Acid (PAN) facility. They
were then PCR amplified, transcribed, and purified using the methods described
above. The RPM and Enrichment values for all 22 sequences in the given rounds
are given in Table 2.4. n.d. means not detected (<20 copies in the raw data).
77
Name
RPM
Round
3
RPM
Round
3-B
RPM
Round
3-R
Fitness
Round 3
Fitness
Round
3-B
Fitness
Round
3-R
R3-1 157406 8281 571285 6.34 0.05 3.63
R3-2 111565 11302 95829 13.01 0.10 0.86
R3-3 110502 13082 1417 6.04 0.12 0.01
R3-4 96745 707584 2473 8.43 7.31 0.03
R3-5 95075 7517 1740 10.04 0.08 0.02
R3-6 2295 574 130 25.90 0.25 0.06
R3-7 165 n.d. n.d. 22.08
R3-8 131 n.d. n.d. 21.29
R3-9 195 n.d. 175 20.92 0.90
R3-10 3249 2173 142 17.19 0.67 0.04
R3-B-1 26 1102 n.d. 42.67
R3-B-2 25 422 n.d. 17.20
R3-B-3 106 1213 n.d. 8.44 11.45
R3-B-4 172 1493 n.d. 4.30 8.67
R3-R-1 5609 n.d. 28654 1.89 5.11
R3-R-2 7201 n.d. 18279 0.38 2.54
R3-R-3 14488 n.d. 8753 1.93 0.60
R3-R-4 47 n.d. 708 15.16
R3-R-5 18 n.d. 249 13.61
R3-R-6 7 n.d. 82 11.44
R3-R-7 39 n.d. 399 10.26
R3-R-8 8 n.d. 76 10.17
Table 2.4: Reads-per-million (RPM) and fitness (enrichment) values for the
sequences obtained after high-throughput sequencing. n.d. means that the
sequence was not detectable above 20 copies in the raw data. No entry in fitness
means that the fitness value was uncomputable due to the sequence being
undetectable in either the current or previous round.
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2.4.8 Measurement of aptamer fluorescent properties
The following sequence was ordered, amplified using a suitable primer set, tran-
scribed, and purified to yield MGA which was used for direct comparison of se-
quence performance: 5′-TAATACGACT CACTATAGGG AACACTATCC GACTGGCACC
CCCCTGCCAG GTAACGAATG AAGTGCTTTT CTCGATCTCG TGACCCGCGC AC-
TAGTCGCG AAGGTGTATG TCCTTGGTCA TTAGGATCC-3′.
A stock MG concentration was prepared in PBS-T buffer (1X PBS pH 6.1, 0.01% Tween-20)
and subjected to serial dilutions from 20 µM to 20 nM in the same buffer. The concentration
of MG was measured using a NanoDrop spectrophotometer (Thermo Scientific) and calculated
with an extinction coefficient of 148,900 cm-1/M at 618 nm [162] after allowing MG to equilibrate
overnight in PBS-T. Assays were prepared in flat-bottomed 96-well MicroFluor 2 plates (Thermo
Fisher Scientific) at a final concentration of 100 nM RNA, 5 mM MgCl2, and 0.01% Tween-20,
with MG concentrations ranging from 10 nM to 10 µM. Wells were excited using the Tecan
M1000 Plate Reader at 630±20 nm, and emission was measured at 675±20 nm. For each MG
concentration measured, an RNA-free standard was measured and subtracted from the signal
as a baseline. The signals were plotted at each MG concentration and least-squares fit to a 1:1
complexation model using a custom MATLAB script according to Equation 2.1 as described.
Sλ values were obtained by comparing the integral of the excitation and emission spectra
for each aptamer to that of MGA across the regions used for excitation (610−650 nm) and
emission (655−695 nm) measurements. Excitation/emission profiles were obtained as described
below and fit to a polynomial using MathCad (Parametric Technology Corporation).
We confirmed the obtained φF for R3-B-4 by performing an RNA titration in the PBS-T
buffer at 5 mM MgCl2. We prepared each RNA concentration at a final concentration of 500 nM
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MG and performed serial dilutions of MGA from 10 µM to 10 nM. For R3-B-4 we measured
fluorescence at an RNA concentration of 26 µM and performed a serial dilution from 10 µM to
10 nM. This was done using the Tecan M1000 and measured under the described conditions.
The data was fit to the equation previously described [55].
2.4.9 Measurements of excitation and emission profiles
Solutions containing 1X PBS, 5 mM MgCl2, 3 µM MG, and 1 µM RNA at pH
6.1 were prepared for each aptamer, and excitation and emission spectra were
measured on a UV spectrophotometer in a quartz cuvette (Hellma Analytics). The
measurements were performed in triplicate, and a base-line corrected average was
obtained after subtracting an RNA-free standard from the measurement.
2.4.10 Minimization of red-shifted motif
A total of 7 sequences were characterized that exhibited a unique, red-shifted
emission profile with a maximum at 675nm. These sequences (Spectral Family 1)
were found to have a conserved motif near the 3′ end of the random region and
likely included parts of the reverse primer region based on mfold software [166,167].
The predicted hairpin was minimized by removal of single base pairs and by
measuring the fluorescence response. Each motif variant was prepared at a concen-
tration of 500 nM and incubated with 1 µM malachite green in PBSMT buffer
80
at pH 6.1. The minimization experiment showed that a short, 15nt motif (5′-
AACGUAACGGCCGAC-3′) is minimally required for activation of malachite
green while still exhibiting this unique red-shifted emission profile. This hairpin is
significantly shorter than the active motif identified from MGA and could find
use in the development of aptamer switches, in vivo expression, or in RNA origami
where smaller sequences are preferred.
2.4.11 Molecular cloning of aptamer expression vectors
To generate vectors for expression of R3-B-4 and the scaffolded tR3-R motif
(Figure 2.11 B) under the control of a U6 promoter, the pAV-U6+27 plasmid [174]
was purchased from Addgene (catalog 25709). The DNA sequences for R3-B-4
and tR3-R were synthesized as gBlocks (Integrated DNA Technologies) with a
5′ SalI digestion site and a 3′ XbaI digestion. The cloning strategy and point of
insertion was conducted as previously described [173].
2.4.12 Mammalian cell culture
HEK 293 cells were thawed into a 10cm tissue culture plate coated with 0.1%
gelatin in DMEM/F12 buffer (Thermo Fisher) supplemented with 10% Fetal Bovine
Serum. Once ≈90% confluent, the cells were dissociated using 0.25% Trypsin
EDTA (Thermo Fisher) and 5x105 cells were reverse transfected with 50 g of
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plasmid using Lipofectamine 2000 (thermo Fisher) in 6 well plates according to the
manufacturers specifications. 48 hours post-transfection, the cells were dissociated
using 0.25% Trypsin EDTA and resuspended in Tyrodes solution (136 mM NaCl,
5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose, 10 mM HEPES, pH 7.4)
containing MG-ester before being analyzed with FACS.
2.4.13 Effect of internal spacer on primers
It should be noted that we found that a 72-atom spacer is necessary to separate
the amino coupling from the first nucleotide in both the FP and poly-T primer
sequences that are displayed on the FP beads. When these oligonucleotides were
conjugated to the beads without a spacer, PCR efficiency was dramatically reduced;
we believe this results from steric effects. This was further tested by conjugating an
amino-dPEG24-t-butyl ester (Quanta BioDesign) to the surface of the beads using
EDC, deprotecting the spacer by incubating three times with 100% trifluoroacetic
acid (TFA) for 30 minutes, and then using EDC to conjugate amino-modified
primers containing no internal 72-atom spacer to the surface of the beads before
lastly passivating any unreacted carboxyl groups in the manner described above.
We compared the PCR efficiency of 1) beads functionalized with a 72-atom
internal spacer, 2) beads displaying dPEG24 on the surface coupled to amino-
modified primers, and 3) beads displaying no 72-atom spacer nor dPEG24 and
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coupled to amino-modified primers. We found that the PCR efficiency of 1) and
2) were similar, while we were unable to display DNA on the surface of 3) (data
not shown).
Next, we determine the PCR efficiency of 4) beads displaying both i) amino-
modified poly-T primer with no internal spacer, and ii) a dPEG24 coupled to
amino-modified FP with no internal spacer; and 5) beads displaying both i) amino-
modified FP with no internal spacer, and ii) a dPEG24 coupled to amino-modified
poly-T with no internal spacer. We found that we were able to display DNA on the
surface of 4) but not 5) (data not shown). This indicates that the FP was occluded
in 5) likely due to steric effects. For this reason, we always used a 72-atom spacer
between the surface of the beads and all of the displayed primers.
2.4.14 Effect of poly-A tail on aptamer performance
During GRAP display, newly-transcribed RNA sequences incorporate a 3′ 25-nt
poly-adenosine (poly-A) tail that enables hybridization to capture strands on the
surface of the FP beads. Though the poly-A tail and poly-T capture strand are
exactly the same length, the poly-A tail does not need to be fully complementary
with the poly-T capture strand in order for the RNA to be immobilized. Thus, it is
possible that regions of the poly-A tail may therefore play a role in aptamer folding.
For this reason, dissociation constants and brightness values were determined for
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all 23 aptamers both with and without the poly-A tail regions. Having assessed
the performance of both the poly-A(+) and poly-A(-) versions of each sequence,
we have reported data for only the more functional of the two variants of each
aptamer. It is important to note that future selections using GRAP display must
be aware that the poly-A tail may effect the performance of the final aptamer,
though the effects of the poly-A tail were often very minimal.
We had also attempted to immobilize the RNA using a capture strand of
defined sequence (i.e. not a poly-A) that was complementary to a region of the
reverse primer in the RNA strand. Likely due to steric effects and the inability for
the RNA tail to ”burrow” into the displayed primers, we were unable to coat FP
beads that were prepared as described above with RNA. For this reason, we used
a poly-A/poly-T capture mechanism for all of our described experiments.
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Chapter 3
Re-evolving Known Aptamer
Motifs for Improved Function
3.1 Introduction
In nature, species adapt to environments that apply a selective pressure which
favors the survivability of some individuals over others. Usually, these changes
are so slight as to have almost no effect on survival of an individual. However,
on rare occasions, an inheritable difference between individuals can result in an
advantageous trait that, over multiple generations, can come to dominate a gene
pool. This is the principle behind both natural and directed evolution.
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Most DNA sequences that are present in a random pool used for SELEX
are indistinguishable from one another under selective pressure - they neither
perform nor survive. However, some of these contain a functional gene, or ”motif,”
that allow them to survive in the given environment and, over many rounds of
selective pressure, come to dominate a pool. Oftentimes, these functional motifs
are identified upon SELEX convergence because of sequence similarity between
otherwise very different aptamers.
In SELEX, the designed libraries generally contain from 20− 80 random bases,
yielding a theoretical sequence diversity of 1012 ≈ 1048. Under normal laboratory
conditions, a population of fewer than 1015 sequences (≈ 1 nanomole) are able
to be tested. Thus, only a minute subset of total sequence space is generally
explorable using directed evolution. While short functional motifs may occur
multiple times in a population of this size, highly functional sequences generally
comprise multiple interacting motifs and are thus exceedingly rare [64]. For example,
the preQ1 riboswitch is the shortest aptamer known in nature at 34nt
[97]. The
sequence complexity of a motif this long is 434 = 3x1020. It is these more longer,
more complex, and increasingly rare motifs which are desired from a selection
as we search for more functional aptamers, as increased complexity means more
opportunity for an aptamer to interact with and act upon its target in unique and
interesting ways.
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Thus, the biggest concern with any particle-based selection techniques is that
approaching a sequence diversity rivaling that of SELEX is not possible. This is
because the throughput of FACS is only ≈ 108 per hour. In these approaches, other
methods of reducing library diversity are required, such as limiting the total amount
of diversity by reducing the number of random bases, or by performing a handful
of SELEX rounds prior to initializing the display method. In PD, for example,
2 rounds of traditional SELEX are generally performed in order to reduce the
diversity of the starting library to a throughput reconcilable with FACS. However,
for many targets of interest, functional pre-existing aptamers already exist, and
performing an entirely new selection may not yield meaningful improvement, or
can fail spectacularly due to the biases previously discussed (Section 1.6.2).
In this Chapter, we apply a method of reducing the starting diversity of a
random library needed to find functional aptamers. To do this, we destabilize
and then segmentally randomize a known functional motif and perform three
rounds of GRAP display to yield brighter and higher-affinity sequences than the
best described malachite green aptamer. This method works by biasing a library
towards functionality, and using directed evolution to identify novel sequences that
perform well. Even with a theoretical diversity far in excess of what is explorable
with GRAP display, we identify sequences from our library that perform far better
than those discovered in Chapter 2. Importantly, this is done without any pre-
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enrichment using traditional SELEX showing that GRAP display can be easily
applied to optimize known aptamer sequences. Next, we discuss the rationale for
our current design, and propose design parameters for future mutagenized libraries
that can optimally explore the sequence space around a known motif using any
method of directed evolution. Lastly, we discuss the applications of this method
for yielding improved aptamer sequences for fluorescence-enhancing and other
functional aptamer motifs.
3.2 Results and Discussion
3.2.1 Re-Evolving a Known Motif for Improved Function
Using GRAP Display
MGA-m contains two short helices which are divided by a central, asymmetric, 11
base bulge (Figure 3.1). Both helix 1 (containing the 5′ and 3′ ends of the sequence)
and helix 2 are not considered to be responsible for binding MG, rather their primary
role is stabilizing the binding pocket [175]. For this reason, we decided to destabilize
helix 1 in the design of our library. Particularly, we were interested in evolving
additional bases in this region that, through tertiary interaction or structural
stabilization, could yield better performance. This could result from stabilized
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(lengthened) helix stem region of MGA-m or through tertiary interactions of the
scaffold with the functional pocket of MGA-m.
First, we removed 8 bases from MGA-m that are necessary to stabilize the
MG-binding pocket. Next, we inserted the reduced motif into the center of two
15-base random regions (Figure 3.1). We wished to show that the functional
performance could be improved through additional stability or tertiary interactions.
In this library, the exact MGA-m sequence should be fully present in about
1:65,536 (1 sequence in 48)
We next performed three rounds of GRAP display as previously described by
first subjecting this library to two consecutive emulsion reactions that transform
it into a library of GRAPs. These were then incubated with 50 nM malachite
green and analyzed using FACS. Because we expect stabilization of the conserved
MGA motif to yield fluorescence-enhancing aptamers with identical excitation and
emission profiles, only particles that fluoresced above background in the 670± 30
emission window were collected. The brightest particles were then PCR amplified
for the next round of selection. This process was repeated and the concentration
of free MG was reduced from 50 nM at the start, to 1 nM in Round 1, and
500pM in Round 2. Round 3 GRAPs were prepared as described, but no further
enrichment was observed at concentrations below 500pM MG and we deemed this
pool converged (See Methods).
89
Figure 3.1: A) Secondary structure of MGA-m showing active binding pocket.
Boxed is the region that was inserted into a starting library and flanked by a total
of 30 random bases.
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Name
Sequence (5′ → 3′) of core region
conserved MGA-m region is bolded
MG-D1 ACACGCCATTGTCCTCCGACTGGCGAGAGCCAGGTAACGAATGAGGTTTCTAAGTGTA
MG-D2 ACACGCCATTGTCCTCCGACTGGTGAGAGCCAGGTAACGAATGAGGTTTCTAAGTGTA
MG-D3 CAGATAATCGGATTCCCGACTGGCGAGAGCCAGGTAACGAATGGGCCGGTTTCTGTGT
MG-D4 CCTTTAAGGGGCTCGCCGACTGGCGAGAGCCAGGTAACGAATGCGAGGCTCGGAAAAG
MG-D5 CGCCCAGGATCTCTGCCGACTGGCGAGAGCCAGGTAACGAATGCAAGACGTCCCCTGT
MG-D6 CGCCTCCAATTTGG CCGACTGGCGA AGCCAGGTAACGAATGCCAATAGCCCCTCCG
MG-D7 CGTACCATAAGGCCTCCGACTGGCGAGAGCCAGGTAACGAATGAGGGGATTAACACTC
MG-D8 CGTACCATAAGGCCTCCGACTGGCGAGCGCCAGGTAACGAATGAGGGGATTAACACTC
MG-D9 CGTACCATAAGGCCTCCGACTGGCGAGGGCCAGGTAACGAATGAGGGGATTAACACTC
MG-D10 GGTCTTAATGGTAAGCCGACTGGCGAGAGCCAGGTAACGAATGGCACGCGACAAACCA
Table 3.1: 10 sequences were identified from HTS for further characterization.
Sequences were not found to be effected by a poly-A tail, and were characterized
without. In bold is the conserved region of the library. Due to random PCR error,
some mutations and deletions occur in this region.
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At this point, we performed HTS of the Round 2, and Round 3 pools and
2−4×106 sequences were identified from each pool. Using a custom MATLAB script
and the Bioinformatics Toolbox, we filtered and ranked all sequences based on their
copy number (abundance) and fractional increase in copy number over the previous
round(enrichment or ”fitness”) as described in Section 2.2.4. We were particularly
interested in sequences with an enrichment value greater than 1 (which were
thus represented more than in the previous round) because previous studies have
shown that enrichment can be a better predictor of sequence performance than its
abundance [132,134]. After this analysis, we chose the five most abundant sequences
and the five most enriched sequences in Round 3 for a total of 10 sequences that
were subjected to further characterization (Table 3.1). We characterized MGA-m
and MGA alongside these 10 sequences in order to see how well a segmentally
randomized library can ”re-evolve” the function of MGA-m.
3.2.2 Fluorescence Performance of Identified Sequences
Sequences were characterized using the methods previously described (Section
2.2.6 and Methods Section 2.4.8). In calculating Kd and φF , Sλ was set to 1 for
all sequences because different excitation and emission profiles were not observed.
This is expected given the conserved binding mode (same binding pocket) of MG
with these sequences and MGA.
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Of the 10 sequences identified through HTS and sequence analysis, every one
exhibited fluorescence enhancement of malachite green. MG-D10 and MGA-m
(the 38-base minimized motif) both exhibited affinities above the concentration
range probed in our characterization so dissociation constants were unable to be
reported. The remaining sequences all exhibited similar or higher affinity than
MGA. Two sequences, MG-D3 and MG-D8, showed improved FE than MGA
(Figure 3.2). This is noteworthy because previous in vivo attempts at mutating a
FE aptamer did not result in improved FE [110]. Though the Kd value calculated
for MGA differs from that previously measured (2.2.6), they are within error
of one another (measured Kd = 103.0 ± 31.0 compared to previously measured
Kd = 61.0± 13.4). Kd and FE values are shown in Table 3.2 and plotted in Figure
3.2.
MG-D7 was the most abundant sequence in Round 3 indicating that it was
most consistently enriched over the 3 rounds of GRAP display. Interestingly, the
sequence exhibiting the highest enrichment, MG-D8, differs from MG-D7 by
only a single nucleotide and in the conserved region of MGA-m. This mutation
was evidently introduced as a random PCR error but provided a significant enough
performance enhancement so as to be highly enriched during the sorting process.
Furthermore, MG-D8 was found to exhibit a ≈ 4-fold quantum yield increase
over MG-D7 at the cost of a ≈4-fold decrease in affinity. This is interesting
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Name Kd (nM)
Fluorescence
Enhancement
(fold increase) φF
MG-D1 63.6 ± 6.2 1638 ± 37 0.130
MG-D2 59.6 ± 5.4 1445 ± 30 0.115
MG-D3 44.4 ± 19.8 2799 ± 270 0.222
MG-D4 60.2 ± 17.1 1338 ± 87 0.106
MG-D5 42.9 ± 9.8 1262 ± 62 0.100
MG-D6 55.6 ± 16.5 1224 ± 81 0.097
MG-D7 42.4 ± 7.1 1064 ± 38 0.084
MG-D8 112.4 ± 53.9 4602 ± 565 0.365
MG-D9 30.3 ± 4.5 995 ± 30 0.079
MG-D10 n.d n.d n.d
MGA 103.0 ± 31.0 2360 ± 179 0.187
Table 3.2: Characterization results of identified sequences. Equations 2.1 and
2.3 were used to calculate the Kd, fluorescence enhancement (fold increase over
background), and φF of each aptamer. Reported are the mean and standard
deviation of samples prepared and measured in triplicate.
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Figure 3.2: Kd and FE (relative to background) of aptamers discovered using
GRAP display through segmentally randomizing MGA-m. Sequences MG-D8
and MG-D3 were measured to be brighter than MGA, with MG-D3 exhibiting
a significantly improved affinity. Error bars are representative of standard
deviation from measurements prepared and measured in triplicate.
95
because it shows a single nucleotide is responsible for both increased quantum
yield and a decreased affinity in the same aptamer. This grants further evidence
that fluorescence enhancement has little or no correlation to affinity and that only
GRAP display can effectively and reproducibly isolate functional aptamers even
under a vast abundance of higher affinity sequences.
3.2.3 Stability improves Performance
While accurate prediction of tertiary structure is beyond the capabilities of available
technologies, we can predict the secondary structure of the discovered sequences
and suggest reasons for improved performance. For example, mfold structures of
many characterized aptamers show what look to be significantly stabilized stem
regions of the functional motif. Sequence MG-D3 (Figure 3.3) has a helix 1 region
with 17 predicted base pairs (up from 4 in MGA-m), which is stable and long
enough to adopt a more complex tertiary structure. This could explain both its
greatly enhanced fluorescence and high affinity compared to MGA and MGA-m.
Previous studies using RNA Spinach have shown that correcting mismatches and
bulges in the functional region can lead to improved affinity and brightness [141].
Possibly, MG-D3 could be made to perform better through correcting or deleting
the mismatched pairs of the full structure.
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Figure 3.3: Predicted mfold folding of the active regions of MGA and MG-D3
including nearby stabilizing regions. In this structure prediction, MGA was
truncated by 58 nts on the 3′ end, while MG-D3 is truncated by 11 nts on the 5′
end and 17 nts on the 3′ end. MG-D3 is expected to have a longer and more
stable stem region than MGA which could result in the improved fluorescence
enhancement and binding affinity towards MG. MGA [107] contains a different
hairpin motif than MGA-m [55] which was used in the design of our library.
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3.2.4 Mutations in Conserved Motif Results in Modified
Function
Aptamers MG-D7,MG-D8, and MG-D9 are distinct from one another by a
single base mismatch (X) at the same position in the four-base loop of helix 2
(Figure 3.4. In MGA-m, helix 2 was identified as a GNRA-type tetraloop through
crystallization [175]. GNRA-type tetraloops are named for the sequences which form
them (i.e. 5′-GNRA-3′). Here, N can be any base (A, U, C, or G), while R is a
purine base (either A or G).
GNRA-type tetraloops fold to yield an unusual G:A base pair between their
first and fourth bases. Additionally, in all described tetraloops, the ”N” nucleobase
is stacked with the ”R” nucleobase. In the crystal structure of MGA-m, however,
the A16′ of GAGA is flipped out of place, compared to the canonical GNRA-type
tetraloop position [175]. Instead, it is predicted to interact with the preceding G15′.
In their analysis, Baugh et al. predicts that the flipping of A16′ is an artifact of
crystallization. They also predict that the helices and GNRA-tetraloop appear to
play no role in affecting the aptamer active site. The results of this selection seem
to contradict these claims and could be worth pursuing in later studies.
The most stable predicted structure for MG-D7, MG-D8, and MG-D9 all
suggest a misfolded binding pocket (Figure 3.4). Nonetheless, MG-D7 contains
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Figure 3.4: Predicted folding of MG-D7, MG-D8, and MG-D9 which differ
from one another by a single base mismatch (X) yet have wildly varying activity.
This suggests that the identified base plays an important role in either 1)
stabilizing the binding pocket of MGA-m, or 2) interacting with MG in the
binding pocket.
containing GAGC-tetraloop. This change results in a 4-fold decrease in binding
affinity, and 4-fold increase in MG enhancement.
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While it is possible that the GAGC-tetraloop in MG-D8 merely has a destabi-
lizing effect on the structure and results in an unknown interaction that increases
fluorescence enhancement of MG, this does not explain the insensitivity to a
GAGG-tetraloop. The crystal structure of this motif suggests that A16′ undergoes
base-base stacking with the preceding base, yet this was dismissed as a crys-
tallization artifact. However, G-G stacking is a very common phenomenon in
G-quadruplex, and favorable G-G stacking would explain the similar performance
of MG-D9 and MG-D7. If A16′ was not undergoing base-base stacking as the
crystal structure implies, we would also expect a change in activity with a GAGG-
tetraloop due to disruption of the G:A base pair between the first and last bases
of the tetraloop. To confirm these suspicions, an interesting experiment would be
to compare the performances of all N16’ point mutations for MGA-m alone.
3.2.5 Statistics of Library Mutagenesis
As seen above and elsewhere [63,110,147,152], point mutations inside a motif can yield
new and improved function. In the search for highly functional aptamers discovered
using particle display, future selections could benefit from doping (introducing
random point mutations into) a library to explore all single-, double-, triple-,
etc. mutants of a known fluorescence enhancing motif. In the ideal case, this
mutagenized library would allow us to fully sample the maximum edit distance from
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the known motif. Here, we discuss a mathematical model on the distribution and
optimization of a mutagenized library [151], how it has been previously applied [110],
and a manner by which to improve it for future library design and particle-based
selection performance.
The diversity of a starting library is dependent on the number of random bases
and the distribution of these bases. Usually, libraries are synthesized with an equal
chance that a random base (N) is A, T/U, C, or G. Then, the maximum diversity
D of most libraries is dependent on length n in the following manner:
D(n) = 4n (3.1)
If we want to explore sequence space around a known motif, we need to begin
with a motif of length n, and apply a mutation rate m to every base. With a
library of correct design, we could then explore all single-, double-, triple-, etc.
(p = 1, 2, 3...) point mutations of this motif. In this example, the distribution of
sequences with p point mutations is given by the binomial coefficient:
(
n
p
)
=
n!
p! · (n− p)! (3.2)
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Starting with a known motif, each base can be independently mutated into
one of 3 other bases. Specifically, the total number of sequence variants with p
mutations from the starting motif is given by
Np(n, p) = (3)
p
(
n
p
)
(3.3)
We wish to design a library such that the maximum number of point mutations
is fully explorable. Thus, we need to determine the distribution of sequences in a
library as a function of a given mutation rate m. Here, we assume at a given m
there is an equal likelihood for mutating into any of the other 3 bases. That is, at
a mutation rate of m = 15%, there is a 5% chance of a base mutating into each of
the 3 other bases, and an 85% chance of the same base remaining unchanged. The
distribution of a mutagenized library as a function of motif length n, mutation
rate m, and number of mutations p follows the binomial distribution as given:
Fm(m,n, p) = (1−m)n−p ·mp ·
(
n
p
)
(3.4)
For a random library containing Ntot sequences, the distribution of sequences
is given:
Nm(m,n, p) = Ntot · (1−m)n−p ·mp
(
n
p
)
(3.5)
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As has been derived previously [151], a mutation rate m and maximum number
of fully-sampled point mutations pmax can be obtained by solving the system of
equations:
(3)p
(
n
p
)
≤ Ntot · (1−m)n−p ·mp
(
n
p
)
(3.6)
∂
∂p
Ntot · (1−m)n−p ·mp
(
n
p
)
= 0 (3.7)
for m and p. To solve explicitly, the binomial function can be replaced by the
gamma function (Γ(n+ 1) = n!) and the equations solved.
3.2.6 Optimization of Library Mutagenesis
Using the described manner of library mutagenesis, a selection was performed
against DFHBI using the known RNA Spinach aptamer [110]. Filonov et al. designed
a library by solving Equations 3.6 and 3.7 such that all mutants with up to p = 8
mutations were present (e.g. n = 54, m = 14%, Ntot = 10
14 and pmax = 8. Note,
the authors inexplicably used a reduced mutation rate from what is given by
solving the system of equations). Next, five rounds of SELEX were performed to
remove non-functional sequences. They then expressed this library into E. coli
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cells and performed an in vivo sort on ≈ 103 colonies using FACS to identify
aptamers which exhibit fluorescence enhancement.
Aside from the enrichment limitations of SELEX in comparison to particle
display (discussed in Section 1.6.2 and Section 1.8.2), this selection is also hindered
by significantly over-representing low p sequences.
Reducing low p sequence redundancy is done by optimizing the design of the
library such that 1) we can fully sample the highest number of point mutations
(pmax); and 2) we have the maximum amount of sequence space covered for p > pmax.
In other words, we want to sample the largest edit distance without unnecessarily
sacrificing the overall diversity of our library by over-representing highly-conserved
(low p) sequences. We can do this by removing the inequality in Equation 3.6 and
solving for m, using pmax obtained from Equations 3.6 and 3.7 :
(3)pmax
(
n
pmax
)
= Ntot · (1−m)n−pmax ·mpmax
(
n
pmax
)
(3.8)
In the example mentioned above, solving Equation 3.8 results in the recom-
mended mutation rate increasing from 14% to 21%. Surprisingly, this still fully
samples all sequences with p ≤ 8 point mutations. Instead, the redundancy of
unique sequences with p = 8 mutations is reduced from an average of 2.1 copies to
only 1. This change also increases the number of point mutations in the average
sequence from n·m = 7.5 to 11 which allows a wider exploration of nearby sequence
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space. Lastly, this reduces the percentage of the pool that is redundant from 42.7%
to 7.5%. Because maximum enrichment for two sequences in SELEX is equal to
the ratio of their Kd values
[164], it is hugely important to reduce representation
of sequences near p = 0 as these sequences are expected to maintain near full
function and will out-compete rarer (on a per-molecule basis), highly mutated,
better-performing aptamers which the selection is intended to find.
Modifying the mutation rate to include more of sequence space using traditional
SELEX may yield only minimal practical improvements due to inherent limitations
on enrichment [164]. However, it would greatly improve particle-based selections by
increasing the breadth of sequence space explored. For example, in optimizing
the same 54-base motif above using GRAP display (Ntot = 10
8) solving Equations
3.6 and 3.7 tells us that an initial optimal mutation rate of 8% allows us to
explore all 1-, 2-, and 3-base point mutations. By solving Equation 3.8, we find
that increasing the mutation rate to 22% still allows us to sample all 1, 2, and
3-base point mutations but with over-representation at p = 0 and p = 1 reduced
significantly. Overall, this method reduces the total number of redundant sequences
in the starting GRAP display library from 38% to only 0.3% (a 37.7% reduction
in redundancy) (Figure 3.5).
While this may seem to bias our library towards highly mutated libraries where
most sequences may not be functional, we are still able to fully sample all sequences
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Figure 3.5: Originally suggested (solid) vs optimized (dashed) library design
using SELEX (blue, Ntot = 10
14) and GRAP display (red, Ntot = 10
8) for the
discussed motif (n=54nt). The total number of sequences possible with p
mutations is given by Equation 3.3 (black dotted line). Shaded regions represent
unnecessary sequence redundancy in the starting library. In the discussed example,
increasing the mutation rate from 14% to 21% can reduce SELEX redundancy by
35.2% to only 7.5% of the starting library. For GRAP Display, increasing
mutation rate from 8% to 22% reduces redundancy by 37.7% to only 0.3% of the
starting library while still sampling all 1-, 2-, and 3-base point mutations.
with p ≤ 3 mutations. Additionally, we expect that these high p sequences are
more able to grant improved function to the starting motif due to their broader
exploration of nearby sequence space.
Due to the phenomenal enrichment possible with particle-based display methods,
we believe this manner of library mutation would still result in significantly
improved sequences when compared with SELEX or in vivo screening. For example,
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Filonov et al. discovered only 6 mutants from the starting SELEX library (m =
14%) that exhibited high FE. 5 of these had p ≤ 3 mutations from the 54-nt
Spinach motif, while the remainder had p = 4 mutations. Using GRAP display,
we would still be expected to sample 5 of these 6 clones from our starting library.
In our view, limitations on SELEX enrichment only allows discovery of sequences
with few point mutations due to their enormous starting (per sequence) abundance
and high likelihood to function (and thus be collected during the partitioning
process).
3.3 Conclusions
There exists a plethora of known aptamer sequences against a variety of targets, but
oftentimes these sequences fall short of optimal or desired function. These short-
comings have lead to the development of numerous selection methodologies, but it
is not always preferable to evolve a new aptamer for every desired function or appli-
cation. For this reason, there have been a number of attempts at improving known
aptamer sequences through incorporating mutagenesis [146,147] into the selection
process using methods such as error-prone PCR [148], library design [151], or random
splicing/recombination [149,150]. Sometimes, rationally mutating bases and segments
of a given motif can improve their performance [136–138,140,141]. These methods allow
for a deeper, more focused exploration of sequence space in the search for the most
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functional aptamers. However, they often suffer from drawbacks, including the
intractability of certain methods of mutagenesis [176], the limited number of features
able to be displayed on a chip, and limitations in our computational and design
capabilities [143–145]. A promising method involves designing a library around a
known aptamer motif and allowing evolution to identify the optimized motif.
We wished to show that GRAP display can overcome physical throughput
limitations in the search for improved functionality. First, we introduced a known
fluorescence-enhancing aptamer motif MGA-m into a segmentally-randomized
library and evolved aptamers that exhibited improved function over the best known
malachite green aptamer MGA. This method works by making all sequences more
resemble a known aptamer motif while providing enough diversity to invoke
improved function. The resulting sequences showed a ≈ 100-fold increase in
affinity and > 10-fold increase in function over MGA-m alone, and a ≈ 2− 5-fold
improved function (both affinity and FE) over the full-length MGA. We attribute
these performance increases to highly-stabilized structural motifs. Interestingly,
one sequence MG-D9 exhibits significantly improved fluorescence enhancement
capability and reduced affinity by introduction of a single base point mutation
in a loop structure believed to be unrelated to MG binding. This result suggests
that the tetraloop (which was previously classified as a GNRA-type [175]) may
belong to a not-yet-described class of tetraloop structures. Lastly, we discussed a
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known method of library design and introduced an optimization step in the process
for designing mutagenized, or ”doped,” libraries. This optimization can more
deeply explore sequence space around a known motif while reducing redundancy
for applicability with particle-based display methods where throughput is limited.
3.4 Methods
GRAP display was prepared and performed in the manner described previously
(Section 2.4). Buffer recipes and reagents remain as previously described. Addition-
ally, sequences were ordered, synthesized, purified, and characterized as described
previously.
3.4.1 DNA preparation
The single-stranded DNA library and all primers used were synthesized by Inte-
grated DNA Technologies. Modified oligos were purified using HPLC, while all
others underwent standard desalting. Randomized bases were hand-mixed at a
25:25:25:25 ratio. The DNA library (Library) consisted of molecules containing a
conserved sequence (28bp) flanked by randomized 15nt regions which were in turn
flanked by conserved PCR primer-binding sequences.
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Identical primers were used as described previously (Section 2.4). Oligos used
in this selection both for use in PCR and to transcribe the control sequences are
as follows:
Oligo Sequence (5′→ 3′)
Library TAATACGACT CACTATAGGG ACACAATGGA CGNNNNNNNN
NNNNNNNCCG ACTGGCGAGA GCCAGGTAAC GAATGNNNNN
NNNNNNNNNN TAACGGCCGA CATGAGAG
MGA TAATACGACT CACTATAGGG AACACTATCC GACTGGCACC
CCCCTGCCAG GTAACGAATG AAGTGCTTTT CTCGATCTCG
TGACCCGCGC ACTAGTCGCG AAGGTGTATG TCCTTGGTCA
TTAGGATCC
MGA-m TAATACGACT CACTATAGGG ATCCGACTGG CGAGAGCCAG
GTAACGAATG GATCC
3.4.2 FACS screening
Prior to screening, we incubated FP beads with malachite green (Spectrum Chemi-
cal) at concentrations ranging from 1 nM to 100 nM in PBSMT pH 7.4 to determine
levels of background and non-specific binding. This is an appropriate baseline,
because ≈80% of particles after ePCR contain no PCR product and thus little to
no RNA, making them indistinguishable from FP beads. We performed FACS
on the Aria II instrument (BD Biosystems), isolating particles that exhibited a
fluorescence signal above background (defined as the sort gate) due to MG activa-
tion and which also exhibited a strong fluorescence signal from the FAM-labeled
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dsDNA. This ensured that only particles which expressed both RNA and its parent
DNA were collected and enriched.
We incubated ≈ 108 particles in round 1 and ≈ 107 particles in all later
rounds. In each round, we performed a similar MG titration as described for
FP beads above, and chose an MG concentration such that ≈ 0.1% of the total
population fluoresced in the reference gate. All incubations were performed at a
bead concentration such that ≈ 5, 000 events/second were registered on the FACS
instrument.
We were not interested in collecting events that emitted at different wavelengths
because we expect only a single emission wavelength. In the 670±30nm channel,
we collected any events that fluoresced higher than the background signal, which
was established as described above, and the sorted particles were directly added
to a PCR mixture and amplified for use in later rounds. Over the course of two
additional rounds of selection, the MG concentration was decreased 100-fold from
50nM in Round 0, to 1nM in Round 1, and 500pM in Round 2. After the second
round of selection, we observed no further enhancement in binding ability of the
Round 3 pool at concentrations below 500pM. The events collected in each round
are as follows:
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Channel: 670± 30nm
Round 1 11,839
Round 2 1,344
Round 3 1,473
3.4.3 Issues with contaminating sequences
GRAP display is incredibly efficient at enriching for highly functional sequences
regardless of their starting copy number. To avoid issues with contamination
stemming from this, it is highly recommended to change the primer sequences on
the library after every new selection performed against the same target, assuming
the first selection yields high affinity sequences. For example, the library (library
2) used in this chapter was ordered simultaneously as the library used in Chapter
2 (library 1). Library 2 was only used for a single pilot experiment, and that
was several months prior to initializing the selection in Chapter 2. Nonetheless,
sequences from library 2 were able to totally out compete library 1 which was
realized upon sequencing. This lead to the failure of our first attempt at finding new
MG aptamers from a na¨ive library. This issue was later combated by performing less-
stringent (higher target concentration) sorts such that we were collecting GRAPs
at event rates above what would be expected from contaminating sequences.
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Chapter 4
In Vitro Directed Evolution of
Riboswitches with GRAP Display
4.1 Introduction
Upon completion of the Human Genome Project in 2003, it rapidly became
apparent that only a small fraction (1− 3%) of our genes directly code for proteins.
A large portion of the remaining ≈ 99%, once termed ’junk DNA,’ has since been
found to be translated into RNA for a number of different purposes. For example,
the Encyclopedia of DNA Elements (ENCODE) Project, which was announced in
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2012 [70], found that ≈ 75% of the genome is transcribed into RNA [71]; albeit much
of it at very low levels [177,178].
The term non-coding RNA (ncRNAs) is simply RNA that does not undergo
direct translation; and it encapsulates miRNAs (microRNA), rRNAs (ribosomal),
lncRNAs (long non-coding), and numerous other types. While ncRNAs are be-
coming relevant in our understanding of cellular biology, the extent, importance,
and purpose of their functions remains largely unknown. However, these RNA
appear to comprise an additional layer of cellular signaling, control, and commu-
nication [179] beyond what is performed by proteins. Of those ncRNAs that are
well described, they exist in roles as diverse as controlling subcellular structural
organization [77,78]; promoting gene silencing [79,80], gene expression [81,82], and stem
cell differentiation [83]; and determining cellular localization of macromolecules [84]
in addition to numerous other functions [81,85,86].
Riboswitches are one manifestation of ncRNA that are often found in the 5′UTR
(untranslated region) of bacterial or viral mRNA. When a riboswitch-specific ligand
- typically a small molecule [96–99] - enters the local environment of these structures,
the finely-tuned thermodynamics of folding shift so as to promote a structural
reorganization and the modulation of downstream genes.
Typically, riboswitches are comprised of three domains: an RNA aptamer,
a transduction region, and an active region [95]. In the natural environment,
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the aptamer interacts with a target ligand which invokes a structural change
in the transduction region. This results in the active region performing one
of many diverse functions [95–97], such as translational control [180], transcription
termination [181], mRNA degradation [180], alternative splicing [182], catalysis [183], or
protein recruitment [184].
While in vivo functions of riboswitches are immensely important, in vitro
applications are an equally exciting platform for their use. In these application
environments, riboswitches are more often referred to as structure-switching ap-
tamers to reflect that they are not RNA-specific. For example, structure-switching
aptamers have been discovered that allow real-time sensing of small molecules [88,89],
metal ions [90,185], and proteins [91,92]. As a relevant example, a structure-switching
target-specific DNA aptamer has been utilized by our lab to measure [93] and then
control [94] the levels of an important cancer drug - doxorubicin - in live animals. If
more highly-functional, structure-switching aptamers were available, these tech-
nologies could become widely applied for arbitrary detection and in vivo control
of numerous targets. This could have huge implications in the deployment of
personalized medicine.
Because of their diverse display of function, riboswitches also have promise for
use in gene-specific and targeted therapies, pharmaceuticals, diagnostics, molecular
sensing, and cellular computing. However, new discovery of riboswitches is hindered
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by their complexity (generally 100-200+ nucleotides in length [186]). This means that
rational design and computational prediction methodologies can not adequately
anticipate their function.
For example, a modular approach to riboswitch engineering yielded a num-
ber of in vivo-functional riboswitches responsive towards the small molecules
SAM, lysine, guanine, FMN, and others. However, their switches were only
amenable to a well-understood (and a mechanistically simply) type of function
(rho-independent transcription termination) and yielded a lower dynamic range
than natural switches [187]. Despite successful implementation with this design tech-
nique, rationally-designed switches do not typically resemble natural riboswitches
which contain long, well-folded transduction regions and perform highly-efficient
switching [97,188].
An alternative approach to rational or computation design of riboswitches is
directed evolution. While some approaches have been applied to discover or engineer
new riboswitches, they are usually only capable of screening 104 to 106 candidates.
This is because they typically rely on in vivo expression platforms that come with
new difficulties and are not amenable to truly high-throughput screening [189–192].
These in vivo methods suffer from drawbacks including heterogeneous riboswitch
expression which necessitates additional normalization [110,193], the difficulty of
performing effective negative or concentration-dependent selections [95], and the
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incompatibility of riboswitches between different domains of life [194,195]. Meanwhile,
in vitro methods have not been widely used as it is difficult to tether activity
(switching) to a handle that allows preferential enrichment of functional switches.
With this understanding, we present a method of evolving riboswitches in vitro
and using previously known aptamers as the recognition and active regions. We
link these regions with a minimally-designed randomized transduction region, and
perform a functional selection to enrich aptamers which become active only in the
presence of their target ligand - adenosine triphosphate (ATP). We compare two
methods of in vitro discovery using GRAP display and compare the discovered
sequences with the best rationally-designed switches of the same class. We report
a number of sequences which exhibit the desired behavior, and show that the most
functional evolved random region does not follow the typical design parameters of
riboswitches. These results suggest GRAP display could find widespread use in
discovering RNA exhibiting novel function.
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4.2 Results and Discussion
4.2.1 Design of a Riboswitch Library for the
ATP-dependent Activation of MG
Previously, a DNA:RNA hybrid aptamer switch has been designed that allows ATP-
dependent fluorescence-enhancement of malachite green using the known MGA-m
motif. With this method, the authors were able to obtain a ≈ 4-fold enhancement
of malachite green in the presence of 1 mM ATP when compared to the absence of
ATP [126]. Other designs have shown controllable ”turn on” fluorescence (≈ 2− 25-
fold enhancement) of chromophores with the addition of SAM, SAH, cyclic di-GMP,
cyclic di-AMP, and cyclic AMP-GMP through incorporating rational design or in
vivo evolution to modify existing function [101–103,196,197]. However, these switches
are far from the dynamic ”on”/”off” switches desired in application. Here, we
intended to show that GRAP display is well-suited for the selection of functional
riboswitches by designing an RNA library for in vitro selection and showing that
this design is capable of resulting in the same reporting functions.
Generally, the process for designing a riboswitch involves first identifying a
suitable target and reporter sequence. Then, these sequences are connected through
a transduction region which incorporates elements of design in order to promote 1)
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minimal interaction between this region and the aptamer regions, and 2) a delicate
energy balance between the ”on” (correctly folded) and the ”off” (misfolded) state
of the switch. Usually, design elements promote a metastable transduction region
that is i) short (1-5base pairs), ii) contains ”weak” base pairs like A-U and G-U,
or iii)has totally mismatched base pairs [101]. In almost all cases, the ”off” state is
designed to be unfolded (non-interacting with either aptamer regions). In this way,
binding the ligand can promote aptamer stabilization and yield correct folding
of the reporter region. Lastly, several riboswitch designs are synthesized and
characterized to determine the best-performing sequence.
In our approach, we wished to allow evolution to design a new riboswitch.
Specifically, we intended to provide only a minimally designed transduction region
and allow GRAP display to identify an aptamer whose two states are finely
balanced such that it performs the desired switching function. We wanted to
use this library to show ATP-dependent ”turn-on” of malachite green only in the
presence of ATP and hoped to identify a transduction region that interacts with
the aptamer regions in the absence of target. While it goes against the principles
of rational design, this behavior more closely mimics natural riboswitch. In this
way, we are not introducing artificial constraints into the structure such as those
that are implemented with rational design. To do so, we began with MGA-m
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Figure 4.1: A) Our library was designed to incorporate the known MGA-m
sequence and an ATP-specific aptamer. We removed stabilizing hairpins from
both structures and connected them with a randomized transduction region.
and a known ATP aptamer [147], and replaced stabilizing structural regions of both
motifs with a randomized transduction region (Figure 4.1).
There were two major considerations when deciding on the length of this
random region. First, we wanted to have a diversity compatible with GRAP
display (≈ 108). Second, we wanted the random region to be semi-stable. If it was
too long, we thought the transduction region may be too stable, or too far extended
to allow structure-switching. If too short, there may be no suitable candidates
that can optimally balance the two switch states. Drawing from known natural
riboswitches, we believed that an optimal transduction region would interact
strongly with the aptamer regions [97] so decided on a longer length than usual
design permits (¿5bp). To balance these considerations and to incorporate some
baseline stability, we chose an 18-base transduction region but inserted a G:C pair
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at both ends of it. In total, we included 14 random bases into our library design
(Figure 4.1 A).
4.2.2 Control Selection for ATP-Dependent Fluorescence
Enhancement using MG-Biased Library
As a control, we performed a selection using GRAP display with the library
described in Chapter 3 (Figure 3.1 B). We wanted to show that ATP alone cannot
significantly stabilize MG binding without additional design of the library. To do
so, we performed two different sorting conditions using GRAP display (Figure 2.1
Steps 3 and 4). The first type was for GRAPs that exhibited bright fluorescence
in the presence of ATP (positive sort). The second type of sort was for GRAPs
that exhibited dim fluorescence in the absence of ATP (negative sort). Sorting
conditions were performed so as to collect only the brightest GRAPs under each
condition(See Methods). In this selection, we performed three rounds of GRAP
display using a positive-negative-positive sorting methodology.
Next, we performed HTS analysis using a custom MATLAB script and the
Bioinformatics Toolbox to identify suitable candidates. We looked for sequences
that exhibited a round-over-round increase in copy number only in the positive sort.
We also looked that these sequences exhibited a round-over-round decrease in copy
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Figure 4.2: 26 sequences were identified after performing 3 rounds of GRAP
display for FE aptamers in the absence and presence of ATP. No sequences
exhibited the desired functionality of having a higher signal in the presence of
ATP than in the absence of ATP (indicated here as a value of 1 or greater).
number when no ATP was present. In total, we identified 26 candidate sequences
which were tested both in the presence and absence of ATP (See Methods).
None of the identified candidates performed the desired ”turn-on” function of
a fluorescent riboswitch (Figure 4.2). This suggests that performing a screen for
both ATP binding and structure-switching is very likely too complex to evolve
with a library diversity of only ≈ 108. Having confirmed that ATP-dependent
turn-on of MG is not a general phenomenon, we continued with the library design
described in Section 4.2.1 (Figure 4.1).
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4.2.3 Evolution of Riboswitches Through Positive and
Negative Selections
In the first of two selection methods, we performed one round of GRAP display from
the na¨ive random library using the ”positive” sort methodology described above.
This helps enrich our pool for sequences that enhance the fluorescence of MG in the
presence of ATP. However, we did not wish our pool to contain ATP-independent
FE sequences, so we performed a ”negative” selection as described. Thus, for a
sequence to be consistently enriched it must fluoresce only in the presence of ATP.
Similar to the control, we performed this selection using a positive-negative-positive
selection methodology and submitted all 4 pools (Round 0, Round 1, Round 2,
and Round 3) for sequencing.
Through HTS analysis (see Methods Section 4.4.5), we identified 16 sequences
which exhibited consistent positive enrichment over the three rounds of selection.
The identified sequences were then transcribed and serially characterized to identify
those that exhibited enhanced fluorescence of MG in the presence of ATP. While
15 of the 16 sequences showed MG fluorescence in the presence of only 1 µM MG,
only 4 sequences (JY-2, JY-3, JY-7, JY-8) showed increased fluorescence in the
presence of 200 µM ATP (Figure 4.3). This represents significant improvement
over the control selection, where all of the identified sequences showed reduced
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fluorescence in the presence of ATP. As an example, we show sequence JY-
2 undergoing ATP-dependent enhancement in the manner desired(Figure 4.4),
consistent with the expected behavior of a riboswitch. Despite this structure-
switching activity, none of these sequences showed multi-fold enhancement in the
presence of MG and ATP compared to MG alone.
4.2.4 Evolution of Riboswitches Through Differential
Screening and HTS Analysis
In our second approach, we wished to rely more heavily on high-throughput
sequencing analysis to identify sequences that enriched preferentially in the presence
of ATP. Rather than relying on ”positive” and ”negative” sorts to enrich performing
sequences, we wished to look for differences in the way that sequences performed
under these conditions.
We performed one round of GRAP display from the na¨ive random library
using the ”positive” sort methodology described above. In the following round, we
divided our collection of GRAPs into two pools, and sorted one under ”positive”
sort conditions, and one under ”negative” sort conditions. In both sorts, we
collected 40,000 events. Because both sorts used the same pool at identical MG
concentrations, we would expect that sequences which activate MG in an ATP-
independent manner should enrich at similar levels. However, sequences that had
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Figure 4.3: 16 sequences were identified from this selection based on enrichment
in the presence or absence of ATP. A) The ability of these sequences to enhance
the fluorescence of MG were tested in the presence and absence of ATP. 15 of
these exhibited significant FE of MG. B) 6 sequences exhibited the desired
functionality of having a higher signal in the presence of ATP than in the absence
of ATP (indicated here as a value of 1 or greater). Fluorescence is in arbitrary
units.
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Figure 4.4: Sequence JY-2 exhibits increased FE of MG with the addition of
ATP. This is consistent with the desired switching functionality of riboswitches.
RNA concentration is 1 µM.
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ATP-dependent activation of MG should enrich at higher levels in the ”positive”
pool than in the ”negative” pool. Upon sorting, the pools were not combined, and
further rounds of ”positive”/”negative” sorting was performed. Lastly, all pools
were submitted for HTS.
Through HTS analysis, we identified 24 sequences that exhibited enrichment
consistent with what would be expected for a ”turn on” fluorescent riboswitch.
Upon characterization (See Methods 4.4.6), we identified 19 of these sequences as
yielding significant fluorescence in the presence of 1µM MG alone. Upon testing
these sequences with the addition of 500 µM ATP, we identified 14 sequences which
exhibited a significant fluorescence increase with the addition of ATP (Figure 4.5).
One sequence, ATP-1.3, was found to have very little fluorescence in the absence
of ATP, but many folds higher fluorescence when ATP was present. This suggests
that the sequence performs a major structural reorganization upon addition of
ATP. Further characterization revealed a ≈ 3− 4-fold increase in fluorescence at 1
µM MG with the addition of 200 µM ATP(Figure 4.6). This is on-par with the
best reported riboswitch [126] for ATP-dependent enhancement of MG. However,
the reported switch is a DNA:RNA chimera containing two ATP binding pockets
which allows a greater energy contribution to structure stabilization upon ligand
binding so the two can not be directly compared.
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Figure 4.5: 24 sequences were identified after performing consecutive sorts using
GRAP display of a single pool in the presence (positive sort) and absence
(negative sort) of ATP. These sequences were positively enriched when ATP was
present, and negatively enriched when ATP was absent indicating a fluorescent
”turn-on” switch. A) The ability of these sequences to enhance the fluorescence of
MG were tested in the presence and absence of ATP. B) 14 sequences exhibit
fluorescence enhancement that is higher in the presence of ATP than without
(indicated here as a value of 1 or greater), suggesting they are behaving as
switches. Due to the low signal of ATP-1.3 in the absence of ATP, we performed
additional characterization to confirm the ≈12-fold increase in FE. Fluorescence is
in arbitrary units.
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Figure 4.6: Sequence ATP-1.3 exhibited a ≈3-fold increase in fluorescence in
the presence of 500 µM ATP relative to no ATP. Measurement was performed at
2 µM MG and 1 µM RNA. Fluorescence is in arbitrary units.
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4.2.5 Structural Analysis of Sequence ATP-1.3
In reported methods of rational design for riboswitches, the transduction region
is designed to be unstable due to i) being short, ii) containing ”weak” base pairs
like A-U and G-U, or iii)having totally mismatched base pairs [101]. We wished to
ascertain whether evolution could provide a method of developing more complex
transduction regions (P2) that preferentially interact with the recognition (P1)
and reporting (P3) regions. This mimics more natural riboswitches which undergo
large structural reorganizations rather than merely going from unfolded to folded
in the presence of their ligand [95,97,188].
We can show GRAP display allows this by comparing the predicted two-state
folding of sequence ATP-1.3 (Figure 4.7). Mfold software predicts a highly stable
inactive structure with the P2 region interacting strongly with P1. Indeed, the
active structure is predicted not to fold as designed due to strong destabilization
in the P2 region which prevents the G:C clamps on either end of the transduction
region from correctly folding. The predicted energy difference of the structures is
nearly 9kcal
mol
. This suggests the MG and ATP provide significant stabilization to
promote folding of the active structure. For reference, many natural riboswitches
exhibit a ∆G for small molecule-RNA interactions from 7− 12kcal
mol
[97].
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While these are only predicted free energies and do not take into account
environmental affects or any of the numerous other potential folding states, we see
that the large RNA:RNA interactions present in ATP-1.3 appear to mimic more
natural riboswitches which incorporate many interactions between the recognition
and active region of the switch. This differs strongly from the mostly unstructured
regions that have been rationally designed [101–103,126,161].
With certainty, we can say that usual methods of rational design would fail to
predict a transduction region such as that in ATP-1.3. This is because of 1) the
long (9bp) length of the P2 region, 2) the strong interactions predicted between
the P2 and P3 regions, and 3) the huge stability difference predicted between the
active and inactive state. Indeed, as we perfect the methods used in this selection,
we believe GRAP display may allow discovery of numerous transduction regions
that would otherwise be difficult or impossible to predict. This could lead to great
advances into the rational design and in vivo or in vitro application of riboswitches.
4.3 Conclusions
Riboswitches are of vast importance in nature where species utilize target-dependent
switching of RNA for functions as diverse as mRNA silencing, cleavage, splicing,
and protein recruitment [95]. However, current methods of riboswitch development
rely on altering known riboswitch structures in an effort to impart additional
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Figure 4.7: mfold structure predicted for sequence ATP-1.3. The inactive state
(misfolded) is predicted to be highly structured and stable with a predicted free
energy of −23.1kcal/mol. The correctly folded state is highly destabilized by the
incorporation of mismatched pairs on either end of the transduction region. The
predicted free energy for this structure is −14.2kcal/mol. This results in a
predicted 3,400,000:1 distribution of the aptamer in the inactive state compared
to the active state.
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function, or laborious in vivo selections for transduction regions. While both
methods have allowed discovery of functional riboswitches for various targets,
neither allows both a thorough analysis of sequence space and easy adaptation to
new targets.
For this reason, we applied GRAP display to search for target-dependent
activation of a fluorescence enhancing RNA. We chose two approaches to address
this problem. In the first, we performed consecutive rounds of ”positive” and
”negative” selection against ATP. In the second, we performed simultaneous rounds
of ”positive” and ”negative” selection using a single pool, and analyzed HTS data
to identify potential candidates. Both methods produced numerous aptamers with
ATP-dependent fluorescence enhancement indicative of switching. One sequence,
ATP-1.3, provided a strong enhancement of MG only in the presence of ATP -
exhibiting performance rivaling the best-designed MG/ATP switch to date [126].
Additionally, the transduction region of this sequence does not appear to follow the
rules usually applied in the rational design of riboswitches. Instead, the predicted
free energies of folding and strong overlap of the transduction region with the
aptamer region more closely mimics the features of natural riboswitches. This
suggests that GRAP display may be an effective manner of evolving switches with
complexity beyond what rational design allows.
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While there remains much to explore in regards to the optimal design of an
evolve-able riboswitch library, we believe these results show that GRAP display
is a promising method of addressing the need for new riboswitches. Not only
can evolution discover switches with complex interactions between the different
regions of a switch, but these interactions more closely mimic natural riboswitches.
Additionally, this manner of library design can be easily applied to any target
with a known aptamer by simply switching out one region of the library with a
new motif and performing 2-3 rounds of GRAP display. Future selections should
yield a number of insights into modular riboswitch discovery towards the goal of
arbitrary cellular computing and control, as well as development of effective in
vitro switches for use as biosensors.
4.4 Methods
GRAP display was prepared and performed in the manner previously described
(Section 2.4). Buffer recipes and reagents remain as previously described. Addition-
ally, sequences were ordered, synthesized, purified, and characterized as described
previously.
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4.4.1 DNA preparation
The single-stranded DNA library and all primers used were synthesized by Inte-
grated DNA Technologies. Modified oligos were purified using HPLC, while all
others underwent standard desalting. Randomized bases were hand-mixed at a
25:25:25:25 ratio. The DNA library consisted of molecules containing a conserved
ATP motif flanked by randomized 7nt regions which were in turn flanked by a
conserved MG motif and further by PCR primer-binding sequences (Figure 4.1).
Identical forward primers were used as described previously (Section 2.4). For
the selections performed in this chapter (except for the control selection), we
redesigned the RP in order to prevent cross-contamination from previous selections.
Oligos used in this selection are as follows:
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Oligo Sequence (5′→ 3′)
Library TAATACGACT CACTATAGGG ACACAATGGA CGGGGATCCC
GACNNNNNNN GGGAAGAAAC TGCGGCGCTT GCCGGCNNNN
NNNGGTAACG AATGGATCC
FP TAATACGACT CACTATAGGG ACACAATGGA CG
RP GGATCCATTC GTTACC
RPpT TTTTTTTTTT TTTTTTTTTT TTTTTGGATC CATTCGTTAC C
FAM-RPpT /56-FAM/-TTTTTTTTTT TTTTTTTTTT TTTTTGGATC
CATTCGTTAC C
AmM-FP /5AmMC6//iSp18//iSp18//iSp18/ /iSp18/-TAATACGACT
CACTATAGGG ACACAATGGA CG
AmM-pT /5AmMC6//iSp18//iSp18//iSp18/ /iSp18/-TTTTTTTTTT
TTTTTTTTTT TTTTT
FP-647 /5Alex647N/-TAATACGACT CACTATAGGG ACACAATGGA CG
FPc-FAM /56-FAM/-CGTCCATTGT GTCCCTATAG TGAGTCGTAT TA
pA-FAM /56-FAM/-AAAAAAAAAA AAAAAAAAAA AAAAA
4.4.2 Control selection
In the control selection, we used the library from Chapter 3 and all oligos as
described there. We performed two rounds of pre-enrichment SELEX using the
methods described in Section 2.4 with ATP immobilized on agarose beads (Sigma,
final concentration ≈2 mM ATP). In Round 1 of pre-SELEX, we eluted the RNA
using free 10 mM ATP (Thermo Fischer Scientific) and 1 µM MG instead of heat.
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In Round 2, we used fewer ATP-agarose beads for an estimated concentration of
200 µM ATP.
We performed the initial (Round 0) GRAP display sort at 1 µM MG and 1 mM
ATP, collecting around 0.2% of the positive population. In Round 1, we reduced
the concentration of MG to 500 nM and collected ≈ 0.1% of particles. In the
negative Round 2 sort, we collected a small fraction of non-fluorescent particles at
50 nM MG. In the final positive Round 3 sort, we collected particles that exhibited
a fluorescent signal at 5 nM MG and 100 µM ATP.
HTS was performed on all pools as described previously, and 24 sequences were
identified that exhibited positive enrichment in the presence of ATP during one or
more rounds. None exhibited a strong enrichment only in the presence of ATP,
which is what we would expect if no functional switches are present in the pool.
Upon characterizing the 24 sequences, we found that none exhibited positive
signal gain upon addition of ATP. We confirmed thsi by preparing Round 1 GRAPs
and incubating them with FAM-labeled ATP. We found that these displayed very
little signal which suggests that we did not have ATP-binding aptamers in the
Round 1 pool.
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4.4.3 Positive and negative selection
We prepared a Round 0 GRAP pool using the new library design. We performed one
round of GRAP display as pre-enrichment, without any pre-SELEX, and collected
fluorescent GRAPs at 1 µM MG and 100 µM ATP. These target concentrations
were used for all further rounds of selection. We collected ≈ 0.1% of the GRAP
population. In all rounds of this selection, we collected ≈30,000 events.
From the Round 1 pool, we collected 0.7% of particles in the presence of ATP
(positive sort). With the Round 2 pool, we collected an arbitrary fraction of the
GRAPs that expressed DNA and did NOT exhibit a strong MG signal (negative
sort). We sorted the Round 3 pool in the presence of ATP and collected ≈ 0.1%
of the brightest GRAPs. All pools were then subjected to HTS
4.4.4 Differential screening selection
In our second selection attempt, we used the same DNA that was prepared from
sorting the Round 0 pool in the first selection attempt. We then prepared a new
aliquot of Round 1 GRAPs.
Round 1 GRAPs (≈ 108 particles) were resuspended in 500 µL TNaTE, and
physically separated into two tubes. The beads were concentrated using the MPC-S
and resuspended into 5mL of PBSMT buffer containing 1 µM MG, each. ATP was
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added to one tube to a final concentration of 100 µM. Both of these tubes were
incubated concurrently, and sorted individually so that the top 0.1% of fluorescent
particles were collected. Approximately 40,000 events were collected from each
pool to yield the R2P (from the positive sort) and R2N (from the negative sort)
pools. For the next round of GRAP display under the same target conditions,
we collected ≈ 31,000 events to yield the R3PP, R3PN, R3NP, and R3NN pools.
GRAPs were again prepared and sorted, whereby ≈21,000 events were collected to
yield the R3PPP, R3PPN, R3PNP, R3PNN, R3NPP, R3NPN, R3NNP, R3NNN
pools. A total of 15 pools were then subjected to HTS.
4.4.5 Sequencing analysis
HTS data was analyzed using the methods described previously. We looked for
sequences that exhibited positive enrichment only when sorted in the presence
of ATP. Though none followed a clear trend of positive and negative enrichment
as expected, we were able to identify 26 sequences from the control selection, 16
from the first selection method(positive-negative-positive), and 24 from the second
selection method(differential sequence analysis).
A control sequence (GGGATCCCGA CCTGGGGTGG GAAGAAACTG CG-
GCGCTTGC CGGCACCCCA GGGTAACGAA TGGATCC), which was fully
paired in the transduction region of the library, was ordered in order to test
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the folding of the library on beads. We neglected to make this sequence differ
enough from the library to assure that it would not be PCR amplified and come
to enrich in our pools. Our sequencing data revealed that our pools were 60− 80%
contaminated by this control sequence, which highly limited our ability to perform
accurate and in-depth sequencing analysis. Indeed, it is a testament to GRAP
display that this control sequence was able to enter our pool through minimal
cross-contamination from shared equipment despite our best efforts to prevent
this. Nonetheless, the identified sequences from the second selection method which
yielded ATP-1.3 are presented in Table 4.1.
4.4.6 Sequence characterization
All sequences from the three discussed selection were ordered from the Protein
And Nucleic acid (PAN) Facility at Stanford University. They were amplified,
transcribed, and purified as described previously. In general, sequences were tested
at one concentration of MG in the presence and absence of ATP. This was done
in order to determine if any sequences exhibited differential functionality. In the
control selection, MG concentration for these initial tests was set at 200 nM and
ATP at 1 mM with RNA at 1 µM (Figure 4.2). For selection methodologies 1 and
2, MG was set at 5 µM MG, ATP at 500 µM, and RNA at 1 µM(Figures 4.3 and
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Oligo Sequence (5′→ 3′)
ATP.1.1 AAGCCCCGGGAAGAAACTGCGGCGCGTGCCGGCAATGTTA
ATP.1.2 TTGGTATGGGAAGAAACTGCGGCGCTTACCGGCATACCGA
ATP.1.3 AGCTCTTGGGAAGAAACTGCGGCGCTTGCCGGCTAGGGCA
ATP.1.4 GAAACTGGGGAAGAAACTGCGGCGCTTGCCGGCGCACGTG
ATP.1.5 TCACGTAGGGAAGAAACTGCGGCGCTTGCCGGCAACAGGA
ATP.1.6 TCTATCCGGGAAGAAACTGCGGCGCTTGCCGGCTTAATGA
ATP.1.7 TCACTGCGGGAAGAAACTGCGGCGCTTGCCGGCGGCTGGA
ATP.1.8 CGCGTGTGGGAAGAAACTGCGGCGCTTGCCGGCCCACACA
ATP.1.9 ACAACTCCGGAAGAAACTGCGGCGCTTGCCGGCGAGGTGA
ATP.1.10 ACCCTCAGGGAAGAAACTGCGTCGCTTGCCGGCCGTGGGT
ATP.1.11 AATTTTAGGGAAGAAACTGCAGCGCTTGCCGGCTTAAATT
ATP.1.12 ATCTTGCGGGGAGAAACTGCGGCGCTTGCCGGCATTAGGT
ATP.1.13 TTTGATCGGGAAGAAACTGCGGCGCTTGCCGGTGATCAGA
ATP.1.14 TCACTGCGGGAAGAAACTGCGGCGCTTGCCGGCATATTGA
ATP.1.15 ACCGTCGGGGAAGAAACTGCGGCGCTTGCCGGCAATAAGA
ATP.1.16 AGTGTGCGGGAAGAAACTGCGGCGCTTGCCGGCTTACACT
ATP.1.17 TCTACGCGGGAAGAAACTGCGGCGCTTGCAGGCATAAAGA
ATP.1.18 TGACACCGGGGAGAAACTGCGGCGCTTGCCGGCAAAATCA
ATP.1.19 AAGTATTGGGAAGAAACTGCAGCGCTTGCCGGCTTCACTT
ATP.1.20 TAGATCCGGGAAGAAACTGCGGCGCTTGCCGGCCAAACTA
ATP.1.21 TCGCGTGGGGAAGAAACTGCGTCGCTTGCCGGCCCAGCGA
ATP.1.22 GTAATAAGGGAAGAAACTGCGGCGCTTGCCGGCAAAGATC
ATP.1.23 TAAGCACGGGAAGAAACTGCGGCGCTTGCCGGCAACAACT
ATP.1.24 TGCGTCAGGGAAGAAACTGCGGCGCTTGCCGGCCCGCGCA
Table 4.1: Sequencing results from the selection method relying on differential
screening and sequence analysis. Shown is only the region containing the
transducing region and ATP motif.
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4.5). The concentrations used for these characterizations were ≈ 5− fold above
the selection conditions used.
Once candidate sequences were identified, they were further tested to confirm
activity. Sequence JY-2 (Figure 4.4) was prepared in duplicate at a final concen-
tration of 1 µM RNA in 0 nM MG, 50 nM MG, 200 nM MG, and 1 µM MG. Then,
ATP was added to one well at each MG concentration and the fluorescence signal
was measured. This process was repeated for concentrations of 100 µM, 500 µM, 1
mM, and 2 mM ATP and the results reported.
Sequence ATP-1.3 (Figure 4.6) was prepared in PBSMT, in triplicate, at a
concentration of 1 µM RNA at ATP concentrations of 0 µM, 100 µM ATP, 200
µM ATP, 500 µM ATP, and 1 mM ATP. These samples were then incubated
at concentrations of 500 nM MG, 2 µM MG, and 5 µM MG and fluorescence
measured using a Tecan M1000 plate reader.
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Chapter 5
Conclusion
5.1 Summary
Over the last decade, we have learned that RNA is a much more complex and widely
applied molecule than originally believed. Rather than being a simple intermediate
between DNA and protein, RNA serves a number of diverse functions in the cell
ranging from regulating gene expression to environmental sensing. However, many
of our directed evolution approaches for developing new functional RNA rely on
enriching sequences based simply on their ability to recognize a target of interest.
Towards expanding the capabilities of directed evolution to discover complex RNA
function, my dissertation demonstrates the unique capabilities of a new approach
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to in vitro RNA selection, termed Gene-linked RNA Aptamer Particle (GRAP)
display, and describes multiple applications where it can be used to develop novel,
highly functional RNA aptamers.
In Chapter 2, we introduced GRAP display - an in vitro selection method
capable of enriching RNA sequences based on their interactions with a fluorescent
target. We demonstrate this capability by performing a selection against the
non-fluorescent small molecule dye, malachite green (MG). Upon binding MG, an
RNA aptamer can enhance the fluorescence in a manner independent of binding
affinity. As such, we were able to demonstrate that GRAP display successfully
identified sequences with desirable fluorescent properties that would otherwise be
missed using SELEX.
We isolated aptamers with affinities ranging from 20 nM to>2 µM, and resulting
in a malachite green quantum yield in excess of 3,800-fold above background.
Additionally, because of the unique manner by which GRAP display measures the
fluorescence output of every individual aptamer species, we showed that we can
intentionally isolate aptamers with distinct spectral properties upon interaction
with a single chromophore. For example, one group of sequences shared a short,
15nt motif that yielded an emission profile for malachite green that was significantly
red-shifted from the known sequence and had an emission maximum of 675nm.
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Lastly, we performed numerous characterization of the discovered aptamers and
demonstrated their utility in in vivo environments.
Next, we applied GRAP display in Chapter 3 for the re-evolution of a known FE
motif in order to improve its function. We showed that, by incorporating additional
structure to the sequence, we could improve on both the affinity and brightness of
the known aptamer. We also saw that one sequence, through incorporation of a
single nucleotide mismatch from other characterized sequences(and in the conserved
motif, no less) exhibited a greatly reduced affinity and increased quantum yield.
The location and effect of this mismatch suggests that the previously-solved crystal
structure appears to show a unique tetraloop folding motif which is in agreement
with the crystal structure but contrary to the views of the original authors.
With the understanding that known library mutagenesis techniques exhibit
massive redundancy that makes them unsuitable for particle-based methods, we
discussed design parameters for future random libraries. Here, we took the known
method of mutagenized aptamer library design and suggested an optimization step
in the design to reduce redundancy in highly-conserved (having a small number of
mutations) sequences. In order to maximize the amount of sequence space capable
of being explored, while also improving the efficiency of selection, we broadly
suggest an increased mutation rate that provides improved sequence diversity for
the non-redundant exploration of sequence space around a known motif.
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With the goal of eventually discovering RNA aptamers exhibiting highly com-
plex and coordinated functions, we next applied GRAP display for the development
of a simple fluorescence-reporting riboswitch which functions by transducing a
target recognition event into a fluorescence output. We designed a random li-
brary that incorporates known motifs for the discovery of an ATP-dependent
fluorescence-enhancing aptamer.
We wished to show that evolution could construct riboswitches that go beyond
the simple design parameters commonly used for riboswitch engineering and instead
produce regions that more closely mimic natural riboswitches. So, we discussed
and performed two new selection methodologies and showed that both are capable
of isolating ATP-dependent riboswitches. One method yielded Sequence ATP-1.3
which exhibits multi-fold FE in the presence of ATP and had a non-conventional
transduction region that does not follow the parameters usually followed during
rational design. This shows that GRAP display is capable of evolving entirely new
riboswitch domains which no other in vitro selection methodology can perform.
RNA is an incredibly functional biomolecule, and particle-based display methods
have repeatedly demonstrated their unparalleled capacity for reliably and effectively
isolating highly functional nucleic acid aptamers. As the first RNA-based particle
display selection methodology, we believe that GRAP display is a profound step
forward towards realizing the ultimate potential and practical uses of functional
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RNA. While I will leave the numerous potential applications of this technique
to the imagination of the reader, I sincerely hope GRAP display can be further
applied towards the evolution of complex RNA machinery capable of more than
simply binding to a target molecule.
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